1
|
Hu Y, Xu ML, Kong XH, Huang YJ. [A case report of pyriform sinus fistula secondary to descending necrotizing mediastinitis and pyothorax]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2024; 59:388-391. [PMID: 38622024 DOI: 10.3760/cma.j.cn115330-20230811-00041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/17/2024]
Affiliation(s)
- Y Hu
- Medical school of Nantong University,Nantong 226001,China Department of Otorhinolaryngology Head and Neck Surgery,Taizhou People's Hospital Affiliated to Nanjing Medical University,Taizhou 225300,China
| | - M L Xu
- Department of Otorhinolaryngology Head and Neck Surgery,Taizhou People's Hospital Affiliated to Nanjing Medical University,Taizhou 225300,China
| | - X H Kong
- Department of Otorhinolaryngology Head and Neck Surgery,Taizhou People's Hospital Affiliated to Nanjing Medical University,Taizhou 225300,China
| | - Y J Huang
- Department of Otorhinolaryngology Head and Neck Surgery,Taizhou People's Hospital Affiliated to Nanjing Medical University,Taizhou 225300,China
| |
Collapse
|
2
|
Suneja G, Huang YJ, Boucher KM, Jr LMB, DeCesaris C, Grant JD, Harkenrider MM, Jhingran A, Kidd EA, Lin LL, Jr WS, Gaffney DK. Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer: Primary Endpoint Results of the SAVE Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 2023; 117:S39-S40. [PMID: 37784490 DOI: 10.1016/j.ijrobp.2023.06.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Prospective trials in early stage endometrial cancer demonstrate increased locoregional control with adjuvant radiotherapy for patients with high risk features. VCB is widely utilized, yet there is substantial practice variation and limited randomized data examining optimal dose/fractionation. We aimed to study the safety and efficacy of short course VCB compared to commonly used regimens. MATERIALS/METHODS We conducted a prospective, randomized, multicenter trial examining short course adjuvant VCB (11 Gy x 2 fractions at the surface) compared with other standard regimens (7 Gy x 3 fractions at 0.5 cm depth, 6 Gy x 5 fractions at the surface, or 5-5.5 Gy x 4 fractions at 0.5 cm depth). Eligible patients underwent hysterectomy and had pathologically confirmed endometrioid adenocarcinoma, serous, clear cell, or carcinosarcoma. Patients with stage I and II cancers were included, with lymphovascular invasion (LVI) required for stage IAG1. The primary outcome was Global Health Status measured by the EORTC QLQ-C30 with a pre-specified non-inferiority margin of 15 points. Secondary outcomes included patient-reported outcomes, toxicities as assessed by CTCAEv5, and patterns of recurrence. Data were collected at each brachytherapy fraction and at 1-, 6-, and 12-month follow-up. RESULTS One hundred eight patients were enrolled, 54 in each study arm. Data completion was 94%, 91%, and 77% at 1 month, 6 months, and 12 months, respectively. 70% of patients had endometrioid adenocarcinoma, 18% serous carcinoma, and 12% other histologies. 23% were FIGO grade 1, 33% grade 2, and 43% grade 3 or high risk histologies. The majority of patients were stage I (56% IA, 38% IB). 22% of patients had LVI. The QLQ-C30 Global Health Status for the experimental arm was within the predefined boundary and thus 2 fractions were non-inferior to standard of care at one month (p = 0.000005) and 12 months (p = 0.0005). Using EORTC EN24 for patient reported vaginal/sexual, urologic, and gastrointestinal symptoms, the change in mean patient reported symptom score from baseline to 1 month and baseline to 12 months were not significantly different between arms. Using CTCAEv5, 51 patients experienced short-term AEs related to study treatment, 20 in the experimental arm and 31 in the control arm (p = 0.053). All study treatment-related AEs were grade 1-2, except for two grade 3-4 AEs, both on the control arm. At median follow-up of 19 months, the isolated vaginal control rate in each arm was 100%. There was no significant difference in the total number of recurrences between study arms, with 3 distant and 3 distant/pelvic/vaginal recurrences in the experimental arm, and 2 distant, 2 pelvic, and 1 pelvic/vaginal recurrence in the control arm. CONCLUSION Short course VCB is safe with acceptable acute toxicity and non-inferior patient reported outcomes. Short course VCB improves patient convenience and may improve access to care for rural or underserved populations while providing similar local control.
Collapse
Affiliation(s)
- G Suneja
- Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - Y J Huang
- Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - K M Boucher
- Huntsman Cancer Institute, Salt Lake City, UT
| | - L M Burt Jr
- Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - C DeCesaris
- Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - J D Grant
- Intermountain Healthcare, Salt Lake City, UT
| | - M M Harkenrider
- Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL
| | - A Jhingran
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - E A Kidd
- Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
| | - L L Lin
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - W Small Jr
- Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL
| | - D K Gaffney
- Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| |
Collapse
|
3
|
Fan YH, Zhang PL, Huang YJ, Xie C, Ai T. Risk factors for recurrent wheezing after bronchiolitis. BMC Pediatr 2023; 23:317. [PMID: 37353732 PMCID: PMC10288744 DOI: 10.1186/s12887-023-04108-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Accepted: 06/02/2023] [Indexed: 06/25/2023] Open
Abstract
BACKGROUND This study aimed to determine whether there was an association between certain factors in patients with bronchiolitis and recurrent wheezing in childhood. METHOD In 2021 we tracked children hospitalized for bronchiolitis at Chengdu Women's and Children's Central Hospital in 2017. The patients were classified into recurrent wheezing group (RWG) and non-recurrent wheezing group (NRWG). Possible risk factors including maternal age, school-age siblings, allergic history, atopic dermatitis, allergic rhinitis, atopic family history, severity of the condition, duration of hospitalization, nasopharyngeal secretions culture, blood eosinophil counts, FeNO and skin prick test were compared between the two groups. Continuous variables were analyzed by independent sample t-test for normal distribution and Mann-Whitney U-test for non-normal distribution. Categorical variables were tested using chi-square tests. Multifactor analysis was conducted by stepwise logistics regression analysis. RESULTS In total 167 participants were included, of which 26 and 141 were in RWG and NRWG respectively. In RWG children represented higher maternal age (P = 0.02) and greater probability of allergic history, atopic dermatitis, allergic rhinitis, atopic family history (odds ratio [OR] = 4.0,3.7, 7.8, 10.9 respectively, P < 0.01). However, school-age siblings, severity of the condition, duration of hospitalization, blood eosinophil counts, fractional exhaled nitric oxide and skin prick test results seemed unrelated to recurrent wheezing. In the subgroup analysis of nasopharyngeal secretion culture, there were more Moraxella catarrhalis-positive in RWG(P = 0.043). Atopic dermatitis, allergic rhinitis and atopic family history were identified as independent risk factors for recurrent wheezing. CONCLUSION Some children with bronchiolitis will develop recurrent wheezing, and the risk factors are allergic history, Moraxella catarrhalis infection or colonization, atopic dermatitis, allergic rhinitis and atopic family history; the latter three are independent risk factors.
Collapse
Affiliation(s)
- Y H Fan
- Department of Pediatric Pulmonary Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China
| | - P L Zhang
- Department of Pediatric Pulmonary Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China
| | - Y J Huang
- Department of Pediatric Pulmonary Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.
| | - C Xie
- Department of Pediatric Pulmonary Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China
| | - T Ai
- Department of Pediatric Pulmonary Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China
| |
Collapse
|
4
|
Pan NF, Liang ZH, Lin P, Wang X, Lin SS, Huang YJ, Chen XX, Pan YC. [Influence factors of poor efficacy after flap repair operation in patients with pressure ulcers]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2022; 38:1156-1161. [PMID: 36594146 DOI: 10.3760/cma.j.cn501225-20220228-00041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Objective: To investigate the influence factors of poor efficacy after flap repair operation in patients with pressure ulcers. Methods: The retrospective case series study was conducted. From January 2011 to June 2021, 125 patients with stage Ⅲ and Ⅳ pressure ulcers treated in Hainan General Hospital met the inclusion criteria. There were 82 males and 43 females, aged 15-90 (57±20) years. According to the postoperative effects, the patients were divided into poor efficacy group (47 cases) and good efficacy group (78 cases). The clinical data of patients in the two groups were collected, including the age, gender, location, stage, size, and bone exposure of pressure ulcers, preoperative microorganism culture results of wound exudate sample, whether combined with osteomyelitis, diabetes, lower limb paroxysmal myospasm, and gatism or not, the number of surgical debridement combined with negative-pressure wound therapy, type of surgical flap, postoperative position, and preoperative albumin, leukocyte, C-reactive protein (CRP), and hemoglobin. Data were statistically analyzed with independent sample t test, Mann-Whitney U test, and chi-square test. The binary multivariate logistic regression analysis was conducted to screen the independent risk factors influencing the poor efficacy after flap repair operation in 125 patients with stage Ⅲ and Ⅳ pressure ulcers. Results: The ratio of patients with lower limb paroxysmal myospasm in poor efficacy group was 22/47, which was significantly higher than 3/78 in good efficacy group (χ2=33.83, P<0.01). The preoperative hemoglobin level of patients in poor efficacy group was (102±17) g/L, which was significantly lower than (113±20) g/L in good efficacy group (t=-3.24, P<0.01). The preoperative CRP level of patients was 39.1 (14.1, 91.6) mg/L in poor efficacy group, which was significantly higher than 15.3 (6.6, 42.0) mg/L in good efficacy group (Z=-3.04, P<0.01). There were no statistically significant differences in other indexes between patients in the two groups (P>0.05). Multivariate logistic regression analysis showed that age, lower limb paroxysmal myospasm, and preoperative hemoglobin level were the independent risk factors for poor efficacy after flap repair operation in patients with pressure ulcers (with odds ratios of 1.03, 40.69, and 0.97, 95% confidence intervals of 1.00-1.06, 9.18-180.39, and 0.95-1.00, respectively, P<0.05 or P<0.01). Conclusions: Poor efficacy after flap repair operation in patients with pressure ulcers is affected by many factors, among which the age, lower limb paroxysmal myospasm, and preoperative hemoglobin level are the independent risk factors.
Collapse
Affiliation(s)
- N F Pan
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - Z H Liang
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - P Lin
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - X Wang
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - S S Lin
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - Y J Huang
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - X X Chen
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| | - Y C Pan
- Department of Burn and Skin Repair, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China
| |
Collapse
|
5
|
Chen KB, Wu ZW, Huang Y, Kang MX, Lin LL, Jiang SS, Zhang H, Huang YJ, Chen L. Successful outcome of neoadjuvant PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy for potentially unresectable esophagogastric junctional squamous cell carcinoma: a case report. Transl Cancer Res 2022; 11:3329-3336. [PMID: 36237240 PMCID: PMC9552059 DOI: 10.21037/tcr-22-789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2022] [Accepted: 07/18/2022] [Indexed: 11/06/2022]
Abstract
Background Case Description Conclusions
Collapse
Affiliation(s)
- Kai-Bo Chen
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Zhi-Wei Wu
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Yi Huang
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Mu-Xing Kang
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Le-Le Lin
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Shan-Shan Jiang
- Department of Pathology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Hui Zhang
- Department of Pathology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Ya-Jing Huang
- Department of Pathology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Li Chen
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| |
Collapse
|
6
|
Xiao M, Kong ZL, Che K, Hu JX, Li Y, Huang YJ, Guo H, Qi MM, Chi JW, Wang YG. The role of mitochondrial fission factor in podocyte injury in diabetic nephropathy. Biochem Biophys Res Commun 2022; 624:40-46. [DOI: 10.1016/j.bbrc.2022.07.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 06/29/2022] [Accepted: 07/06/2022] [Indexed: 12/01/2022]
|
7
|
Geng Z, Dong B, Lv W, Wang Z, Wang X, Huang Y, Wang Y, Xu L. LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588/ROCK1 axis. Diabetol Metab Syndr 2022; 14:21. [PMID: 35090549 PMCID: PMC8796624 DOI: 10.1186/s13098-022-00791-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Accepted: 01/08/2022] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Diabetic nephropathy (DN) is a critical and the most common microvascular complication and its pathogenesis is still faintly understood. Thus, this study was performed to examine the long non-coding RNA ZNFX1 Antisense Gene Protein 1 (lncRNA ZFAS1) biological function and mechanism of regulation in DN. METHOD Human glomerular mesangial cells (HGMC) were induced with high glucose (HG, 25 mM) to establish HG-induced cell viability, pro-inflammation observed in DN. After, target miRNA and mRNA were predicted through Lncbase and Targetscan. Subsequently, the expression of ZFAS1, miR-588, and ROCK1 in DN clinical samples and cell-model was examined through qRT-PCR and western blot analysis. We upheld the targeted interaction between miR-588 and ZFAS1 or ROCK1 through a dual-luciferase reporter assay. The proliferation of the cell was also examined through CCK-8 assay, while the level of HG-induced oxidative stress was established by measuring reactive oxygen species (ROS) level, and also the activities of antioxidant enzymes in the cell. Lastly, the level of accumulated extracellular matrix (ECM) protein-fibronectin and collagen type IV, and inflammatory cytokines produced by the cell was analyzed through western blot analysis and ELISA. RESULTS ZFAS1 was significantly upregulated in the DN blood samples and HG-induced HGMC. Prediction result revealed that the ZFAS1 endogenously targets the miR-588 seed sequence while miR-588 plays a role in post-transcriptional regulation of ROCK1 mRNA. Moreover, we found that miR-588 expression was significantly downregulated in DN blood samples and negatively correlates with ZFAS1 expression. Further results show that silencing ZFAS1 had a protective effect on HG-induced proliferation, oxidative stress, fibrosis, and inflammation in HGMC while miR-588 inhibition and ROCK1 overexpression reversed this effect. CONCLUSIONS Altogether, our data suggest that ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced diabetic nephropathy through the miR-588/ROCK1 axis.
Collapse
Affiliation(s)
- Zhuang Geng
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - Bingzi Dong
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - Wenshan Lv
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - Zhongchao Wang
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - Xiang Wang
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - YaJing Huang
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China
| | - Yangang Wang
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China.
| | - Lili Xu
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, People's Republic of China.
| |
Collapse
|
8
|
Chen KB, Huang YJ, Huang Y, Wu ZW, Jin XL, Zhang H, Xiang XP, Chen L, Chen L. Metastasis of Sarcomatoid Malignant Mesothelioma With p16/CDKN2A Deletion Manifested as a Subcutaneous Mass in the Back: A Case Report and Review of Literature. Int J Surg Pathol 2021; 29:856-863. [PMID: 33729861 DOI: 10.1177/10668969211005094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Sarcomatoid malignant mesothelioma (MM) is a rare and aggressive disease, and its diagnosis is challenging. A 60-year-old man presented with a recurrent subcutaneous mass in his right back after the initial resection. A chest computed tomography (CT) scan found right pleural thickening, nodular pleural thickening, pleural effusion, mediastinal, and right infraclavicular lymph nodes enlargement, which indicated a right pleura MM. Immunohistochemical stains of the resected mass showed sarcomatous atypical spindle cells, which were positive for pan-CKs (clone Anti-cytokeratin cocktail AE1/AE3), cytokeratin 5/6 (CK5/6), Wilm's tumor 1, podoplanin, vimentin and programmed death-ligand 1 (PD-L1), and negative for Napsin A, thyroid transcription factor 1, CDX 2, calretinin and desmin, and fluorescent in situ hybridization detected homozygous p16/cyclin-dependent kinase inhibitor 2A (p16/CDKN2A) deletion. The association of the chest CT features and the pathological assessment confirmed metastatic MM in the subcutaneous layer of the back. Moreover, positron emission tomography-CT showed multiple metastases in his brain. He developed massive right pleural effusion and chest tightness soon, and the mass kept growing despite local and systemic treatments. The patient die of pulmonary failure in 3 months.
Collapse
Affiliation(s)
- Kai-Bo Chen
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China.,Equal contributors
| | - Ya-Jing Huang
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China.,Equal contributors
| | - Yi Huang
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Zhi-Wei Wu
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Xiao-Li Jin
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Hang Zhang
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Xue-Ping Xiang
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Lin Chen
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| | - Li Chen
- Second Affiliated Hospital, 89681Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
9
|
Luo JP, Huang YJ, Xu JY, Sun JF, Dargusch MS, Hou CH, Ren L, Wang RZ, Ebel T, Yan M. Additively manufactured biomedical Ti-Nb-Ta-Zr lattices with tunable Young's modulus: Mechanical property, biocompatibility, and proteomics analysis. Mater Sci Eng C Mater Biol Appl 2020; 114:110903. [PMID: 32994002 DOI: 10.1016/j.msec.2020.110903] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2019] [Revised: 03/25/2020] [Accepted: 03/25/2020] [Indexed: 11/16/2022]
Abstract
Some β-Ti alloys, such as Ti-Nb-Ta-Zr (TNTZ) alloys, exhibit a low Young's modulus and excellent biocompatibility. These alloys are promising new generation biomedical implant materials. Selective laser melting (SLM) can further enable customer-specific manufacturing of β-Ti alloys to satisfy the ever-increasing need for enhanced biomedical products. In this study, we quantitatively determined the relationships between porosity, yield strength, and Young's modulus of SLM-prepared TNTZ lattices. The study constitutes a critical step toward understanding the behavior of the lattice and eventually enables tuning the Young's modulus to match that of human bones. Fatigue properties were also investigated on as-printed lattices in terms of the stress limit. The biocompatibility study included a routine evaluation of the relative cell growth rate and a proteomics analysis using a common mouse fibroblast cell line, L929. The results indicated that the as-printed TNTZ samples exhibited evidence of protein proliferation of the L929 cells, particularly P06733, and that those proteins are responsible for biological processes and molecular functions. They in turn may have promoted cell regeneration, cell motility, and protein binding, which at least partially explains the good biocompatibility of the as-printed TNTZ at the protein level. The study highlights the promising applications of additively manufactured TNTZ as a bone-replacing material from mechanical and biocompatibility perspectives.
Collapse
Affiliation(s)
- J P Luo
- Department of Materials Science and Engineering and Shenzhen Key Laboratory for Additive Manufacturing of High-performance Materials, Southern University of Science and Technology, Shenzhen 518055, China; School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150001, China
| | - Y J Huang
- School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150001, China
| | - J Y Xu
- Department of Materials Science and Engineering and Shenzhen Key Laboratory for Additive Manufacturing of High-performance Materials, Southern University of Science and Technology, Shenzhen 518055, China; School of Mechanical and Mining Engineering, The University of Queensland, Brisbane 4072, Australia
| | - J F Sun
- School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150001, China.
| | - M S Dargusch
- School of Mechanical and Mining Engineering, The University of Queensland, Brisbane 4072, Australia
| | - C H Hou
- Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China
| | - L Ren
- Institute of Metal Research, Chinese Academy of Sciences, Shenyang 110016, China
| | - R Z Wang
- Department of Materials Engineering, University of British Columbia, Vancouver V6T 1Z4, Canada
| | - T Ebel
- Institute of Materials Research, Helmholtz-Zentrum Geesthacht, 21502 Geesthacht, Germany
| | - M Yan
- Department of Materials Science and Engineering and Shenzhen Key Laboratory for Additive Manufacturing of High-performance Materials, Southern University of Science and Technology, Shenzhen 518055, China.
| |
Collapse
|
10
|
Huang YJ, Wang J, Shu WQ. [Evaluation of potential renal acid load for estimating the health effects of drinking water]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:634-637. [PMID: 32842278 DOI: 10.3760/cma.j.cn112150-20200414-00503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
There is a lack of a reliable comprehensive evaluation indicator to access the health effects of drinking water. In recent years, scholars established an indicator to evaluate the comprehensive effect of drinking water on the body's acid-base balance. This indicator came from the potential renal acid load (PRAL) of food and named the potential renal acid load of drinking water. It included several typical anions and cations which are widely found in drinking water. This article reviewed the application, advantages, and disadvantages of PRAL in accessing the effect of drinking water on body acidbase metabolism.
Collapse
Affiliation(s)
- Y J Huang
- Department of Environmental Hygiene, College of Preventive Medicine, Army Medical University, Chongqing 400038, China
| | - J Wang
- Department of Environmental Hygiene, College of Preventive Medicine, Army Medical University, Chongqing 400038, China
| | - W Q Shu
- Department of Environmental Hygiene, College of Preventive Medicine, Army Medical University, Chongqing 400038, China
| |
Collapse
|
11
|
Zong QF, Huang YJ, Wu LS, Wu ZC, Wu SL, Bao WB. Effects of porcine epidemic diarrhea virus infection on tight junction protein gene expression and morphology of the intestinal mucosa in pigs. Pol J Vet Sci 2019; 22:345-353. [PMID: 31269354 DOI: 10.24425/pjvs.2019.129226] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Tight junction proteins are important for the maintenance and repair of the intestinal mucosal barrier. The present study investigated relationships among tight junction protein gene expression, porcine epidemic diarrhea virus (PEDV) infection, and intestinal mucosal morphology in piglets. We compared the expression of six tight junction proteins (ZO-1, ZO-2, Occludin, Claudin-1, Claudin-4, and Claudin-5) between seven-day-old piglets infected with PEDV and normal piglets, as well as in PEDV-infected porcine intestinal epithelial cells (IPEC-J2). We also evaluated differences in mucosal morphology between PEDV-infected and normal piglets. The expression of six tight junction protein genes was lower in PEDV-infected piglets than in the normal animals. The expression of ZO-1, ZO-2, Occludin, and Claudin-4 in the intestine tissue was significantly lower (p⟨0.05) in PEDV-infected than in normal piglets. The expression of Claudin-5 in the jejunum was significantly lower in PEDV-infected piglets than in the normal animals (p⟨0.01). The expression of Claudin-1 and Claudin-5 genes in the ileum was significantly higher in PEDV-infected piglets than in normal piglets (p⟨0.01). Morphologically, the intestinal mucosa in PEDV-infected piglets exhibited clear pathological changes, including breakage and shedding of intestinal villi. In PEDV-infected IPEC-J2 cells, the mRNA expression of the six tight junction proteins showed a downward trend; in particular, the expression of the Occludin and Claudin-4 genes was significantly lower (p⟨0.01). These data suggest that the expression of these six tight junction proteins, especially Occludin and Claudin-4, plays an important role in maintaining the integrity of the intestinal mucosal barrier and resistance to PEDV infection in piglets.
Collapse
Affiliation(s)
- Q F Zong
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
| | - Y J Huang
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
| | - L S Wu
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
| | - Z C Wu
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China
| | - S L Wu
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China.,Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University, Jiangsu Yangzhou 225009, China
| | - W B Bao
- Key Laboratory for Animal Genetic, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China.,Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University, Jiangsu Yangzhou 225009, China
| |
Collapse
|
12
|
Bhardwaj S, Khasani S, Benasher D, Stein EG, Meghal T, Jacoby N, Huang YJ. Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association. Cerebellum 2019; 18:1126-1129. [PMID: 31161534 DOI: 10.1007/s12311-019-01045-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Paraneoplastic cerebellar degeneration (PCD) is a rare disorder that is associated with lung or gynecological malignancies and Hodgkin lymphoma. Neurologic symptoms are commonly the initial presenting sign leading to the diagnosis of an underlying malignancy. We are presenting an Asian male with progressive lower extremity weakness with EBV-positive nasopharyngeal carcinoma (NPC) and anti-Yo antibodies. Peculiarly, transient diffuse leptomeningeal enhancement is seen on MR imaging. This is the first report of PCD associated with NPC and thus illustrates that PCD embodies a boarder set of disease than previously described.
Collapse
Affiliation(s)
- S Bhardwaj
- Department of Internal Medicine (Relocated to New York University as Clinical Instructor and Hospitalist), Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA.
| | - S Khasani
- Department of Neurology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| | - D Benasher
- Department of Hematology and Oncology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| | - E G Stein
- Department of Neuroradiology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| | - T Meghal
- Department of Hematology and Oncology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| | - N Jacoby
- Department of Neurology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| | - Y J Huang
- Department of Hematology and Oncology, Maimonides Medical Center, 4810 10th Avenue, Brooklyn, NY, 11219, USA
| |
Collapse
|
13
|
Guo M, Chao NJ, Li JY, Rizzieri DA, Sun QY, Mohrbacher A, Krakow EF, Sun WJ, Shen XL, Zhan XR, Wu DP, Liu L, Wang J, Zhou M, Yang LH, Bao YY, Dong Z, Cai B, Hu KX, Yu CL, Qiao JH, Zuo HL, Huang YJ, Sung AD, Qiao JX, Liu ZQ, Liu TQ, Yao B, Zhao HX, Qian SX, Liu WW, Forés R, Duarte RF, Ai HS. HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group. JAMA Oncol 2019; 4:54-62. [PMID: 28910431 DOI: 10.1001/jamaoncol.2017.2656] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Importance The outcome of older patients with acute myeloid leukemia (AML) remains unsatisfactory. Recent studies have shown that HLA-mismatched microtransplant could improve outcomes in such patients. Objective To evaluate outcomes in different age groups among older patients with newly diagnosed AML who receive HLA-mismatched microtransplant. Design, Setting, and Participants This multicenter clinical study included 185 patients with de novo AML at 12 centers in China, the United States, and Spain in the Microtransplantation Interest Group. Patients were divided into the following 4 age groups: 60 to 64 years, 65 to 69 years, 70 to 74 years, and 75 to 85 years. The study period was May 1, 2006, to July 31, 2015. Exposures Induction chemotherapy and postremission therapy with cytarabine hydrochloride with or without anthracycline, followed by highly HLA-mismatched related or fully mismatched unrelated donor cell infusion. No graft-vs-host disease prophylaxis was used. Main Outcomes and Measures The primary end point of the study was to evaluate the complete remission rates, leukemia-free survival, and overall survival in different age groups. Additional end points of the study included hematopoietic recovery, graft-vs-host disease, relapse rate, nonrelapse mortality, and other treatment-related toxicities. Results Among 185 patients, the median age was 67 years (range, 60-85 years), and 75 (40.5%) were female. The denominators in adjusted percentages in overall survival, leukemia-free survival, relapse, and nonrelapse mortality are not the sample proportions of observations. The overall complete remission rate was not significantly different among the 4 age groups (75.4% [52 of 69], 70.2% [33 of 47], 79.1% [34 of 43], and 73.1% [19 of 26). The 1-year overall survival rates were 87.7%, 85.8%, and 77.8% in the first 3 age groups, which were much higher than the rate in the fourth age group (51.7%) (P = .004, P = .008, and P = .04, respectively). The 2-year overall survival rates were 63.7% and 66.8% in the first 2 age groups, which were higher than the rates in the last 2 age groups (34.2% and 14.8%) (P = .02, P = .03, P < .001, and P < .001, respectively). The 1-year cumulative incidences of nonrelapse mortality were 10.2%, 0%, 3.4%, and 26.0% in the 4 age groups and 8.1% in all patients. The median times to neutrophil and platelet recovery were 12 days and 14 days after induction chemotherapy, respectively. Five patients had full or mixed donor engraftment, and 30.8% (8 of 26) of patients demonstrated donor microchimerism. Two patients (1.1%) developed severe acute graft-vs-host disease. Conclusions and Relevance Microtransplant achieved a high complete remission rate in AML patients aged 60 to 85 years and higher 1-year overall survival in those aged 60 to 74 years.
Collapse
Affiliation(s)
- Mei Guo
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Nelson J Chao
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Duke Cancer Institute, Durham, North Carolina
| | - Jian-Yong Li
- Department of Hematology, Jiangsu Province People's Hospital, Nanjing, China
| | - David A Rizzieri
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Duke Cancer Institute, Durham, North Carolina
| | - Qi-Yun Sun
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Ann Mohrbacher
- Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Keck School of Medicine of University of Southern California, Los Angeles
| | - Elizabeth F Krakow
- Division of Medical Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle
| | - Wan-Jun Sun
- Department of Hematology, The Second Artillery General Hospital, Beijing, China
| | - Xu-Liang Shen
- Department of Hematology, He Ping Central Hospital of the Changzhi Medical College, Changzhi, China
| | - Xin-Rong Zhan
- Department of Hematology, Central Hospital of Xinxiang City, Xinxiang, China
| | - De-Pei Wu
- Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
| | - Li Liu
- Department of Hematology, The Fourth Military Medical University, Xi'an, China
| | - Juan Wang
- Department of Hematology, Central Hospital of Cangzhou City, Cangzhou, China
| | - Min Zhou
- Department of Hematology, The Second People's Hospital of Changzhou City, Changzhou, China
| | - Lin-Hua Yang
- Department of Hematology, The Second Affiliated Hospital of Shanxi University, Taiyuan, China
| | - Yang-Yi Bao
- Department of Hematology, Central Hospital of Hefei City, Hefei, China
| | - Zheng Dong
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Bo Cai
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Kai-Xun Hu
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Chang-Lin Yu
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Jian-Hui Qiao
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Hong-Li Zuo
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Ya-Jing Huang
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Anthony D Sung
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Duke Cancer Institute, Durham, North Carolina
| | - Jun-Xiao Qiao
- Department of Hematology, The Second Artillery General Hospital, Beijing, China
| | - Zhi-Qing Liu
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Tie-Qiang Liu
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Bo Yao
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | - Hong-Xia Zhao
- Department of Hematology, The Second Artillery General Hospital, Beijing, China
| | - Si-Xuan Qian
- Department of Hematology, Jiangsu Province People's Hospital, Nanjing, China
| | - Wei-Wei Liu
- Statistics Department, The Academy of Military Medical Sciences, Beijing, China
| | - Rafael Forés
- Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Comunidad de Madrid, Spain
| | - Rafael F Duarte
- Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Comunidad de Madrid, Spain
| | - Hui-Sheng Ai
- Department of Hematology and Transplantation, Affiliated Hospital of The Academy of Military Medical Sciences, Beijing, China
| | | |
Collapse
|
14
|
Huang YJ, Ye Y, Huang XN, Feng WW, Chen Q, He CY, Li Z, Wang NR. [Association of maternal nocturnal sleep throughout pregnancy with the early nocturnal sleep of infants]. Zhonghua Er Ke Za Zhi 2019; 57:608-613. [PMID: 31352746 DOI: 10.3760/cma.j.issn.0578-1310.2019.08.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the association between maternal nocturnal sleep during pregnancy and their infants' nocturnal sleep patterns in early infancy by establishing a birth cohort. Methods: In this prospective study,healthy pregnant women and their infants were recruited in Chongqing Health Center for Women and Children from September 2013 to January 2014. A total of 40 healthy pregnant women and their infants were enrolled, and 34 pairs (85%) completed the whole survey. Actiwatch, wearing on the mother's wrist or infant's ankle,was used to monitor nighttime sleep at home for 7 times in total,with 7 consecutive days for each monitoring course. Pregnant women were monitored at 16, 24, 32 weeks gestational age, and were required to finish Pittsburgh Sleep Quality Index (PSQI) scale at the end of each monitoring. Their infants were initially monitored at 14 days after birth, followed by 1(st), 2(nd), and 3(rd) month after birth,with sleep diary recorded by parents. Pearson correlation analysis and multivariate linear regression were used to investigate the potential correlation between these two sleep patterns. Results: The average nocturnal sleep time was (465±53) min throughout pregnancy, with increased trend in the latency of maternal nighttime sleep onset ((30±15), (34±29), (38±30) min) while decreasing of average sleep efficiency ((85±5)%, (84±8)%, (83±8)%). The longest night sleep duration decreased from (382±74) min in the first trimester to (330±83) min in the third trimester (F=4.932, P<0.05), while awakening time after sleep onset (WASO) correspondingly increased from (27±22) min to (53±25) min (F=12.605, P<0.05). In terms of infants, the latency of nighttime sleep onset decreased from (43±33) min on the 14th day to (20±29) min at 3-month of age (t=3.281, P=0.002), while the longest nighttime sleep duration increased from (20±62) min to (265±140) min (t=3.867, P<0.01); meanwhile, the total nocturnal sleep time and the sleep efficiency increased from (373±126) min and (63±28)% to (431±103) min and (75±16)%, respectively (t=2.362, P=0.024; t=2.418, P=0.039, respectively). After adjusting for maternal age and body mass index (BMI), parental educational level and family income, maternal mood, exposure to tobacco and alcohol during pregnancy, method of delivery, as well as infants' gender, feeding patterns and gestational weeks, the regression analysis showed that the total nocturnal sleep time and the longest nighttime sleep duration during pregnancy were positively correlated with the corresponding parameters of their infants at the age of 3 months (B=0.541, 95%CI 0.168-0.914, t=2.882, P=0.005; B=0.310, 95%CI 0.035-0.586, t=2.240, P=0.027, respectively). Conclusions: The total nocturnal sleep time and the longest nighttime sleep duration during pregnancy are positively correlated with the corresponding parameters of their infants in early infancy. Paying more attention to improve maternal sleep quality may facilitate their infants to establish sleep-wake patterns early.
Collapse
Affiliation(s)
- Y J Huang
- Department of Child Health, Chongqing Health Center for Women and Children, Chongqing 400021, China
| | - Y Ye
- Department of Child Health, Chongqing Health Center for Women and Children, Chongqing 400021, China
| | - X N Huang
- United Nations International Children's Emergency Fund China Office of Nutrition and Health and Water and Environment, Beijing 100600, China
| | - W W Feng
- Department of Child Health, Center for Maternal and Child Health, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - Q Chen
- Department of Pathology, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China
| | - C Y He
- Department of Child Health, Chongqing Health Center for Women and Children, Chongqing 400021, China
| | - Z Li
- Department of Child Health, Chongqing Health Center for Women and Children, Chongqing 400021, China
| | - N R Wang
- Department of Child Health, Chongqing Health Center for Women and Children, Chongqing 400021, China
| |
Collapse
|
15
|
Lin HK, Huang YJ, Shih WC, Chen YC, Chang WT. Crystalline characteristics of annealed AlN films by pulsed laser treatment for solidly mounted resonator applications. BMC Chem 2019; 13:30. [PMID: 31384778 PMCID: PMC6661789 DOI: 10.1186/s13065-019-0550-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Accepted: 03/06/2019] [Indexed: 11/10/2022] Open
Abstract
AlN films were deposited on Si substrates using a reactive RF magnetron sputtering process and then the films were annealed by using different laser powers and wavelengths (355 nm, 532 nm and 1064 nm). For all three laser systems, the (002) peak intensity was obviously improved following laser irradiation. The improvement in the crystalline property was particularly obtained in the AlN film processed at 355 nm. In particular, given the use of the optimal laser power (0.025 W), the (002) peak intensity was 58.7% higher than that of the as-deposited film. The resonant frequency and 3 dB bandwidth of a SMR filter with an unprocessed AlN film were found to be 2850 MHz and 227.81 MHz, respectively. Following laser treatment with a wavelength of 1064 nm and a power of 0.25 W, the resonant frequency changed from 2850 to 2858 MHz. Moreover, 3 dB bandwidth changed from 227.81 to 202.49 MHz and the return loss of the filter reduced from 17.28 to 16.48 dB. Overall, the results thus show that the frequency response of the SMR filter can be adjusted and the return loss reduced by means of laser treatment with an appropriate wavelength.
Collapse
Affiliation(s)
- H K Lin
- 1Graduate Institute of Materials Engineering, National Pingtung University of Science and Technology, Pingtung, Taiwan
| | - Y J Huang
- 1Graduate Institute of Materials Engineering, National Pingtung University of Science and Technology, Pingtung, Taiwan
| | - W C Shih
- 2Department of Electrical Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan
| | - Y C Chen
- 2Department of Electrical Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan
| | - W T Chang
- 3Metal Industries Research & Development Centre, Kaohsiung, Taiwan
| |
Collapse
|
16
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [Seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 39:1477-1481. [PMID: 30462957 DOI: 10.3760/cma.j.issn.0254-6450.2018.11.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China. Methods: This was a retrospective study which involved patients hospitalized for asthma exacerbation in 29 hospitals throughout 7 geographic areas in the mainland of China (northeast, north, central, east, south, northwest and southwest). The numbers of asthmatic patients and total inpatients of the respiratory department of each hospital were recorded. The monthly ratio of asthmatic patients to the total inpatients in every area was calculated and compared. Results: During the study period, 6 480 patients were admitted for asthma exacerbation, accounting for 3.14% of all the 206 135 patients admitted to the respiratory departments in the 29 hospitals. The ratio of asthmatic patients to total inpatients in the northeast area (5.61%) was highest, and the ratio in east area was lowest (1.97%). Statistical analysis showed that the difference among different areas was significant (P<0.000 1). In most areas, both the number and proportion of hospitalized asthmatic patients peaked in spring (February-April) and autumn (September-October). In the northeast area, east area and south area, the peaks in spring were more obvious, while in the north area and southwest area, the peaks in autumn were more obvious. In the northwest area the peaks occurred in winter (December-January) and summer (June-August), respectively. The differences in hospitalization due to asthma among different months were significant in the northeast, north, and southwest areas (P<0.005). Conclusion: The number of patients hospitalized for asthma exacerbation fluctuated with season in different areas in China. In most areas, more asthmatic patients were admitted to hospitals in spring and autumn.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - B Xing
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - H P Tang
- Department of Respiration, Qingdao Municipal Hospital, Qingdao 266000, China
| | - L Yang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y D Yuan
- Department of Respiration, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Y H Gu
- Department of Respiration, Qinghai People's Hospital, Xining 810007, China
| | - P Chen
- Department of Respiratory Diseases, The General Hospital of Shenyang Military, Shenyang 110016, China
| | - X J Liu
- Department of Respiration, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China
| | - J Zhang
- Department of Pulmonary and Critical Care Medicine, The Second Hospital of Jilin University, Changchun 130041, China
| | - H G Liu
- Department of Respiration, Tongji Hospital, Wuhan 430030, China
| | - C Z Wang
- Department of Respiration, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
| | - W Zhou
- Department of Respiration, General Hospital of Ningxia Medical University, Yinchuan 750004, China
| | - D J Sun
- Department of Pulmonary and Critical Care Medicine, Inner Mongolia People's Hospital, Hohhot 010017, China
| | - Y Q Chen
- Department of Respiration, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - Z C Chen
- Department of Respiration, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - M Huang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
| | - Q C Lin
- Department of Respiration, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
| | - C P Hu
- Department of Respiration, Xiangya Hospital, Changsha 410008, China
| | - X H Yang
- Department of Pulmonary and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
| | - J M Huo
- Department of Respiration, The First Affiliated Hospital of Harbin Medical University, Harbin 150081, China
| | - X W Ye
- Department of Respiration, Guizhou Provicial People's Hospital, Guiyang 550002, China
| | - X Zhou
- Department of Respiration, Shanghai Center Hospital, Shanghai 200025, China
| | - P Jiang
- Department of Respiration, Tianjin First Center Hospital, Tianjin 300192, China
| | - W Zhang
- Department of Respiration, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y J Huang
- Department of Respiration, Hainan Provincial People's Hospital, Haikou 570311, China
| | - L M Dai
- Department of Respiration, Kunming General Hospital of the People's Liberation Army, Kunming 650032, China
| | - R Y Liu
- Department of Respiration, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - S X Cai
- Department of Respiration, Nanfang Hospital, Guangzhou 510515, China
| | - J Y Xu
- Department of Respiration, Shanxi Dayi Hospital, Taiyuan 030032, China
| | - J Y Zhou
- Department of Respiration, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| |
Collapse
|
17
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [Seasonal characteristics of patients hospitalized for asthma exacerbation in China]. Zhonghua Yi Xue Za Zhi 2019; 97:2324-2328. [PMID: 28822447 DOI: 10.3760/cma.j.issn.0376-2491.2017.30.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the seasonal characteristics of patients hospitalized for asthma exacerbation in China. Methods: This was a retrospective study which involved patients hospitalized for asthma exacerbation in 29 hospitals throughout mainland China during 2013-2014. The number of patients hospitalized for asthma exacerbation in each hospital was calculated, as well as the ratio of asthmatic patients to all the hospitalized patients. The analysis by month was conducted. The number and ratio of asthmatic patients in the northern and southern cities were calculated respectively. Results: During the study period, there were 6 480 patients hospitalized for asthma exacerbation, accounting for 3.14% (6 480/206 135) of all the hospitalized patients of the respiratory department in 29 hospitals. The analysis by month showed that the ratio of patients hospitalized for asthma exacerbation was highest in March (3.49%), then declined from April to June, then rose again from July, reaching a second peak at September (3.28%), and then declined again from October to December. The ratio of asthmatic patients in every month was higher in northern cities than in southern cities. Conclusions: The ratio of patients hospitalized for asthma exacerbation in China fluctuates with the changes of seasons, and March and September are the two peak months. Northern cities have a higher ratio of asthmatic patients than southern cities.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [Warning symptoms of asthma attack and asthma self-management: a national asthma control survey from China]. Zhonghua Yi Xue Za Zhi 2019; 97:2329-2332. [PMID: 28822448 DOI: 10.3760/cma.j.issn.0376-2491.2017.30.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate warning symptoms of asthma attack and evaluate asthma self-management status of asthma patients in urban China. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out from 30 general hospitals dispersed in 30 provinces of mainland China (except for Tibet) during Oct 2015 to May 2016. Information of frequency and warning symptoms of asthma attack, the time from warning symptoms to asthma attack, the impact of asthma attack and asthma self-management were collected from asthma patients of outpatient department. Results: Altogether 3 875 asthmatic outpatients were recruited. 78.1% (3 026/3 875) of the patients reported restriction of exercise and daily activities during asthma exacerbation. 82.5% (3 160/3 829) of the patients had warning symptoms before asthma attack, the most common warning symptoms were cough, chest tightness and shortness of breath. The median time from warning symptoms to asthma attack was 2 h, the mean time was 90 h. Only 4.4% (167/3 829) of the patients had definite confidence to control asthma when symptoms deteriorated. 76.7% (2 937/3 828) of the patients used medications to control asthma when asthma symptoms deteriorated. Medication choice: inhaled corticosteroid (ICS) + formoterol 45.8% (1 776/3 875), short-acting beta-agonist (SABA) 23.9% (927/3 875). Conclusions: Most asthma patients have warning symptoms before asthma attack, the most common symptoms are cough, chest tightness and shortness of breath. The proportion of patients conducting effective asthma self-management remains low.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Fu YX, Wang YH, Tong XS, Gong Z, Sun XM, Yuan JC, Zheng TT, Li C, Niu DQ, Dai HG, Liu XF, Mao YJ, Tang BD, Xue W, Huang YJ. EDACO, a derivative of myricetin, inhibits the differentiation of Gaoyou duck embryonic osteoclasts in vitro. Br Poult Sci 2019; 60:169-175. [PMID: 30722674 DOI: 10.1080/00071668.2018.1564239] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
1. This study determined the effects of (E)-3-(2-(4-(3-(2,4-dimethoxyphenyl)acryloyl)phenoxy)ethoxy)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (EDACO) on the differentiation of Gaoyou duck embryonic osteoclasts cultured in vitro. 2. Bone marrow mononuclear cells (BM-MNC) were collected from 23-d-old Gaoyou duck embryos and induced by macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand in the presence of EDACO at different concentrations (i.e. 10, 20, 40, 80 and 160 µM). Tartrate-resistant acid phosphatase (TRAP) staining and resorption ability determination were conducted. 3. Results suggested that EDACO suppressed the shaping of positive multinucleated cells and the number of TRAP-positive cells in the 20, 40, 80 and 160 μM EDACO groups was significantly decreased (P < 0.05 or P < 0.01). Besides, the absorption activity of differentiated duck embryonic osteoclasts was significantly inhibited (P < 0.05) in both 80 and 160 μM EDACO groups. 4. Overall, EDACO can inhibit the differentiation of BM-MNC into mature osteoclasts in duck embryos.1.
Collapse
Affiliation(s)
- Y X Fu
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - Y H Wang
- b State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering , Guizhou University , Huaxi District , Guiyang , 550025 , PR China
| | - X S Tong
- c College of Veterinary Medicine , Yangzhou University , Yangzhou , 225009 , PR China
| | - Z Gong
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - X M Sun
- d Department of Clinical Medicine , Bengbu Medical College , Bengbu , 233030 , PR China
| | - J C Yuan
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - T T Zheng
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - C Li
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - D Q Niu
- e Department of gynaecology and obstetrics , The Second Affiliated Hospital of Bengbu Medical College , Bengbu , 233030 , PR China
| | - H G Dai
- f Animal husbandry and veterinary bureau of Fengyang County , Chuzhou , 233100 , PR China
| | - X F Liu
- g Department of surgical oncology , The First Affiliated Hospital of Bengbu Medical College , Huaxi District , Bengbu , 233030 , PR China
| | - Y J Mao
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - B D Tang
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| | - W Xue
- b State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering , Guizhou University , Huaxi District , Guiyang , 550025 , PR China
| | - Y J Huang
- a Department of Bioscience , Bengbu Medical College , Bengbu , 233030 , PR China
| |
Collapse
|
20
|
Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [The level of asthma control in China from a national asthma control survey]. Zhonghua Jie He He Hu Xi Za Zhi 2019; 40:494-498. [PMID: 28728272 DOI: 10.3760/cma.j.issn.1001-0939.2017.07.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To assess the overall asthma control level in urban China. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 provinces in China (except Tibet). Asthmatic outpatients who met the inclusion criteria were recruited consecutively from 30 sub-centers from October 2015 to May 2016. Data of demographic characteristics, asthma control, asthma management, asthma exacerbations and self-management, and disease perception were collected by face-to-face interviews. Results: Totally 3 875 asthmatic outpatients were recruited. Asthma control level was assessed according to GINA 2015. The prevalence of asthma control was 28.5%(1 099/3 854). Among 10 cities, which were also involved in the asthma control survey in 2008, the level of asthma control improved from 28.7% in 2008 to 39.2%(533/1 361) in 2016. The rate of hospitalizations due to asthma exacerbations was 26.4%(1 017/3 858) and the rate of emergency visits was 22.4%(864/3 858). Among adult patients, 18.4%(568/3 092) of them had been absent from work while 63.6%(63/99) adolescent patients had been absent from school because of asthma attacks in the previous year. Conclusion: Although the level of asthma control in China is still far from ideal at present, the status has been improved in some cities. Poorly controlled asthma resulted in increase of hospitalizations, emergency department visits and work/school absences.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A multi-center retrospective study of clinical characteristics and hospitalization costs of patients hospitalized for asthma exacerbation in China during 2013-2014]. Zhonghua Jie He He Hu Xi Za Zhi 2019; 40:830-834. [PMID: 29320830 DOI: 10.3760/cma.j.issn.1001-0939.2017.11.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the characteristics of patients hospitalized for asthma exacerbation in 29 teaching hospitals in China and to evaluate the hospitalization costs of these patients. Methods: This was a retrospective study and involved patients hospitalized for asthma exacerbation in 29 hospitals throughout China during 2013-2014. Information about the demographic features, conditions before the admission, the outcome, the complications, and the costs was collected using the pre-designed case report form. The influencing factors of the hospitalization costs were analyzed. Results: 3 240 asthmatic patients (1 369 males and 1 871 females) were included and data were analyzed. There were 41.5% (1 346/3 240) patients who had a history of previous hospitalization or emergency department visits during the last year. Only 28.0% (907/3 240) patients had used asthma-controlling medications regularly before the admission. Seventy-three(2.3%) patients were admitted to ICU and used mechanical ventilation. Mortality among these patients hospitalized for asthma exacerbation was 0.25% (8/3 240). The median hospitalization costs was 9 045(6 431, 13 035) RMB. The costs of medications, examinations and treatment accounted for 52.1%, 27.6%, and 9.6% respectively. The costs of asthma medications accounted for only 22.7% of the total medication costs, while the costs of antibiotics accounted for 44.0%. The patients who were admitted to ICU, used mechanical ventilation, complicated with pneumonia, or had a history of hospitalization or emergency department visits during the last year due to asthma exacerbations tended to cost more. Conclusion: In this study, we demonstrated that only a minority of the patients had used asthma controllers regularly before the admissions with exacerbations. The in-hospital mortality of asthma patients in this study was much lower than that reported in other countries. The average cost of hospitalization was much higher than the yearly cost of maintenance therapy. Medication was the predominant component of the total hospitalization costs, and the costs of antibiotics made up the major part of the total medication costs.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Shi DZ, Zhang XF, Huang YJ, Luo ZQ. [Course and prognosis analysis of intratympanic dexamethasone in the treatment of sudden sensorineural hearing loss]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019; 32:1696-1699. [PMID: 30716797 DOI: 10.13201/j.issn.1001-1781.2018.22.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Indexed: 11/12/2022]
Abstract
Objective:To compare the recovery of different times of intratympanic dexamethasone in the treatment of sudden sensorineural hearing loss(SSNHL) and investigate the related prognostic factors. Method: Ninety patients with SSNHL were randomly divided into group A(3 times, every 2 days) and group B(5 times, every 2 days) according to the times of intratympanic dexamethasone. All patients were treated with blood flow promoting agents and neural nutrients. After 2 weeks of treatment, the recovery was compared. Based on treatment outcomes, patients were divided into two groups: recovery and no recovery, we evaluated the possible prognostic factors. Result:In the group A, the threshold improvement was(20.2±16.7) dB HL and the overall recovery rate was 78.7%(complete recovery rate, marked recovery rate and recovery rate were 17.0%, 21.3% and 40.4%, respectively), in the group B, the threshold improvement was(20.4±17.4) dB HL and the overall recovery rate was 81.4%, the complete recovery rate, marked recovery rate and recovery rate were 20.9%, 32.6% and 27.9%, respectively, the differences of recovery variables between the 2 groups were not statistically significant. After 2 weeks of treatment, 71 patients got overall recovery(78.9%), 19 patients(21.1%) resulted in no recovery, Interval between onset of symptoms and therapy of recovery group was shorter than that in no recovery group [(5.6±3.6)days vs. (7.7±4.0)days, P<0.05], the presence rate of vertigo in recovery group was lower than that in no recovery(14.1% vs. 68.4%, P<0.01). Gender, ear side, age, concurrence of tinnitus, initial hearing threshold, times of intratympanic dexamethasone and audiogram have no influence on the prognosis of SSNHL. Conclusion:SSNHL patients treated with 3 times and 5 times of intratympanic dexamethasone got similar results. Earlier treatment and absence of vertigo lead to favorable hearing results.
Collapse
Affiliation(s)
- D Z Shi
- Department of Otolaryngology Head and Neck Surgery, the Second Hospital University of South China, Hengyang, 421001, China
| | - X F Zhang
- Department of Otolaryngology Head and Neck Surgery, the Second Hospital University of South China, Hengyang, 421001, China
| | - Y J Huang
- Department of Otolaryngology Head and Neck Surgery, the Second Hospital University of South China, Hengyang, 421001, China
| | - Z Q Luo
- Department of Otolaryngology Head and Neck Surgery, the Second Hospital University of South China, Hengyang, 421001, China
| |
Collapse
|
23
|
Cerin E, Sit CHP, Wong SHS, Huang YJ, Gao GY, Lai PC, Macfarlane DJ, Barnett A. Relative contribution and interactive effects of psychological, social, and environmental correlates of physical activity, sedentary behaviour, and dietary behaviours in Hong Kong adolescents. Hong Kong Med J 2019; 25 Suppl 2:34-39. [PMID: 30674706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Open
Affiliation(s)
- E Cerin
- School of Public Health, The University of Hong Kong
| | - C H P Sit
- Department of Sports Science and Physical Education, The Chinese University of Hong Kong
| | - S H S Wong
- Department of Sports Science and Physical Education, The Chinese University of Hong Kong
| | - Y J Huang
- Department of Physical Education, Hong Kong Baptist University
| | - G Y Gao
- Department of Physical Education, Hong Kong Baptist University
| | - P C Lai
- Department of Geography, The University of Hong Kong
| | - D J Macfarlane
- Institute of Human Performance, The University of Hong Kong
| | - A Barnett
- School of Exercise and Nutrition Sciences, Deakin University, Australia
| |
Collapse
|
24
|
Xing B, Lin JT, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A retrospective study of the treatment of patients hospitalized for asthma exacerbation in China]. Zhonghua Yi Xue Za Zhi 2018. [PMID: 29534393 DOI: 10.3760/cma.j.issn.0376-2491.2018.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the treatment of patients hospitalized for asthma exacerbation in China. Methods: This was a retrospective study and involved patients hospitalized for asthma exacerbation in 29 hospitals throughout China during Jan 2013 to Dec 2014. Information of the demographic features, the severity of the exacerbation, the medicine prescribed during the hospitalization and the use of mechanical ventilation were collected and analyzed. Results: During the study period, there were 3 240 patients hospitalized for asthma exacerbation, and 1 369(42.3%) of them were males 1 871(57.7%)were females. Patients of mild, moderate, severe, and life-threatening exacerbation counted for 41.7%, 37.8%, 19.2% and 1.0%, respectively of the total patients. Of all the patients, 72.6% used bronchodilators by nebulizer, 70.8% used inhaled corticosteroids by nebulizer, 60.5% used intravenous corticosteroids, 17.3% used oral corticosteroids, and 80.5% used antibiotics. The percentages of patients using systemic corticosteroids and antibiotics were higher in patients with more severe exacerbation. In patients with mild exacerbation, there were 74.9% and 52.2% who used antibiotics and systemic corticosteroids, respectively. A total of 73 patients (2.3%) used mechanical ventilation, and 62 of them used noninvasive ventilation, 16 used invasive ventilation, and 5 used both. Conclusions: Nebulizer therapy has been accepted as the main administration route of medicine in the treatment of asthma exacerbation. A large amount of patients used antibiotics and systemic corticosteroids during hospitalization, indicating there may be some overuse of these medicines.
Collapse
Affiliation(s)
- B Xing
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Wang WQ, Lin JT, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [Evaluation of asthma disease perception from China national asthma control survey]. Zhonghua Yi Xue Za Zhi 2018; 98:467-471. [PMID: 29429262 DOI: 10.3760/cma.j.issn.0376-2491.2018.06.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: In order to evaluate disease perception of asthma patients in urban China and provide evidence for further specific patient education. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 general hospitals dispersed in 30 provinces of mainland China (except for Tibet) during Oct 2015 to May 2016. Information of disease perception [Question 1: the disease nature of asthma; Question 2: medication choice of first-line in chronic asthma; Question 3: the occasion of using short-acting aerosols of receptor agonists; Question 4: perception of asthma treatment goal; Question 5: reason for not using peak flow meter (PFM)] were collected from asthma patients of outpatient department. These results were compared with the same type of survey results from 2007-2008. Results: Altogether 3 875 asthmatic outpatients were recruited. 69.0% (2 660/3 857) of the patients had right perception on the disease nature of asthma, 60.2% (2 321/3 857) of the patients considered inhaled corticosteroids (ICS)/inhaled corticosteroids plus long-acting beta2-agonists (ICS+ LABA) as daily-used first-line medication for chronic asthma. 85.7% (3 277/3 823) of the patients had right perception on the condition of using short-acting beta2-agonists (SABA). 75.4% (2 761/3 661) of the patients had right perception on asthma treatment goal. Only 10.1% (388/3 837) of the patients used PFM. Of the reasons for not using PFM, 65.2% (2 518/3 860) of the patients chose doctors never introduced. Among the 10 cities, which were also involved in the asthma control survey in 2007-2008, 71.1% (968/1 361) of the patients had right perception on the disease nature of asthma, 61.6% (839/1 362) of the patients considered ICS/ICS+ LABA as daily-used first-line medication for chronic asthma. 88.7% (1 207/1 361) of the patients had right perception on the condition of using SABA. 74.5% (1 013/1 360) of the patients had right perception on asthma treatment goal. 17.9% (244/1 360) of the patients used PFM. Of the reasons for not using PFM, 76.2% (931/1 221) of the patients chose doctors never introduced. Compared to the survey conducted in 2007-2008, the perception on disease nature and medication choice as daily-used first-line medication for chronic asthma significantly improved, the perception on occasion of using SABA and asthma treatment goal was comparable, while the rate of PFM usage showed no significant improvement. In reasons of not using PFM, doctors never introduced ranked the first. Conclusions: Compared to the similar survey conducted in 2007-2008, the overall status of disease perception of asthma patients has been improved in urban China, while the rate of PFM usage showed no significant improvement. Asthma education on asthma and asthma self-management should be further pushed forward.
Collapse
Affiliation(s)
- W Q Wang
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A retrospective study of the mortality and death-related risk factors of patients hospitalized for asthma exacerbation in Chinese urban areas]. Zhonghua Yi Xue Za Zhi 2018; 98:2760-2763. [PMID: 30220175 DOI: 10.3760/cma.j.issn.0376-2491.2018.34.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the mortality and death-related risk factors of patients hospitalized for asthma exacerbation in Chinese urban areas. Methods: A retrospective study was carried out in 29 hospitals of 29 provinces throughout mainland China. Patients hospitalized for asthma exacerbation during 2013-2014 in each hospital were included. For each patient, information about demography, admission time, comorbidities, severity of diseases, intense care unit (ICU) admission, use of mechanical ventilation and the outcome was obtained. The mortality of patients hospitalized for asthma exacerbation was calculated, and the basic information and causes of death of the patients who died were summarized. The death-related risk factors and numbers of comorbidities were compared between the patients who survived and those who died during hospitalization. Results: A total of 3 240 patients (median age 57.0) were included and among them 8 patients (median age 68.5) died. The mortality of patients hospitalized for asthma exacerbation was 0.25%. All the patients who died were admitted during the winter and spring. One patient died of acute myocardial infarction, one of cardiac shock, one of tension pneumothorax, one of sudden death, one of respiratory failure and three of unknown causes. The average number of comorbidities of patients who died was 1.10, larger than that of patients who survived (0.83) (P>0.05). More patients had diabetes, coronary artery diseases and hypertension as comorbidities in the patients who died (2/8) than those who survived[7.6% (246/3 232), 7.6% (246/3 232), 22.6% (731/3 232), respectively](all P>0.05). Conclusions: The in-hospital mortality of patients hospitalized for asthma exacerbation of China in this study is low. The patients who died are much older, and with more comorbidities, and a higher percentage of comorbidities such as diabetes, coronary artery diseases, and hypertension.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Centre for Respiratory Medicine, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Wu X, Li J, Joypaul K, Bao WW, Wang D, Huang YJ, Li PC, Mei W. Blood flow index as an indicator of successful sciatic nerve block: a prospective observational study using laser speckle contrast imaging. Br J Anaesth 2018; 121:859-866. [PMID: 30236247 DOI: 10.1016/j.bja.2018.05.065] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Revised: 04/10/2018] [Accepted: 06/07/2018] [Indexed: 01/22/2023] Open
Abstract
BACKGROUND Laser speckle contrast imaging allows real-time, non-invasive, quantitative measurements of regional blood flow. The objectives of this prospective observational study were to use laser speckle contrast imaging to evaluate blood flow changes after sciatic nerve block, and to determine whether this novel optical technique can evaluate block success. METHODS This observational study included 63 adult patients undergoing elective lower limb surgery with sciatic nerve block. Blood flow images and blood flow index (BFI) values of toes were recorded using laser speckle contrast imaging 5 min before nerve block and at 5 min intervals until 30 min after sciatic block. The sensitivity, specificity, and cut-off value of laser speckle contrast imaging for predicting successful sciatic block were determined by receiver operator characteristic (ROC) curve analysis. RESULTS The BFI values of toes were significantly increased at each time point after successful sciatic block, compared with the baseline value obtained 5 min before nerve block; in failed sciatic block, there were no significant differences. For successful sciatic block, the highest increase of BFI value was at the big toe. BFI increase of the big toe at 10 min after sciatic block has great potential as an indicator of block success. The area under the ROC curve was 0.954 at a cut-off value of 8.48 perfusion units (PU) with a sensitivity of 89% and a specificity of 100%. CONCLUSIONS Laser speckle contrast imaging might be an early, objective, quantitative, and reliable indicator of successful sciatic block. BFI increase of the big toe not reaching 8.48 PU within 10 min after sciatic block indicates block failure. CLINICAL TRIAL REGISTRATION NCT03169517.
Collapse
Affiliation(s)
- X Wu
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Li
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Anaesthesiology, Shenzhen Second People's Hospital, Shenzhen, China
| | - K Joypaul
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Anaesthesiology, Flacq Hospital, Centre-de-Flacq, Mauritius
| | - W W Bao
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Anaesthesiology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China
| | - D Wang
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y J Huang
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - P C Li
- Britton Chance Center for Biomedical Photonics, School of Engineering Sciences, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, China.
| | - W Mei
- Department of Anaesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| |
Collapse
|
28
|
Nong Y, Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [A multi-center study for the association between the perception and control of disease among asthmatic patients in Chinese urban areas]. Zhonghua Yi Xue Za Zhi 2018; 97:1425-1429. [PMID: 28535631 DOI: 10.3760/cma.j.issn.0376-2491.2017.18.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the current perception of disease among asthmatic patients in Chinese urban areas, and to address its association with asthma control. Methods: This was a nationwide, multi-center, cross-sectional study covering 30 third-level, grade A hospitals in 30 provinces, municipalities and autonomous regions (not including Tibet) across Chinese mainland. The survey was carried out from October 2015 to May 2016. Asthmatic outpatients were selected to receive face-to-face questionnaire survey on asthma control including Asthma Control Test (ACT) score, classification of asthma control level[according to the Global Initiative for Asthma (GINA) 2015 classification system, as assessed by the physician completing the survey], perception of asthma (including question 1: nature of asthma as a disease; question 2: selection of first-line therapeutic agents to be regularly used daily for asthma; question 3: appropriate timing of the use of short-acting aerosols of β(2) receptor agonists; and question 4: therapeutic goals for asthma). Results: A total of 3 875 asthmatic outpatients were included; among them, 69.0% (2 660/3 857) were aware that asthma is "an airway inflammatory disorder resulting from the combined effects of heredity and environment" ; 60.2% (2 321/3 857) considered "inhaled glucocorticoids or their compound preparations" to be the first-line therapeutic agents to be regularly used daily for patients with persistent chronic asthma; 85.7% (3 277/3 823) considered it appropriate to use short-acting aerosols of β(2) receptor agonists "as needed in the event of disease aggravation or acute exacerbation" ; and 75.4% (2 761/3 661) were aware that asthma "can be adequately or completely controlled in the long term" . The ACT score[20 (16, 23) vs 19 (16, 22) points; Z=-3.928, P<0.001]and asthma control rate (29.92% vs 25.31%; χ(2)=8.616, P=0.003) were significantly higher, and the rate of uncontrolled asthma (19.92% vs 23.48%; χ(2)=6.267, P=0.012) was significantly lower among the 2 660 (69.0%) patients correctly answering question 1 than among the 1 197 (31.0%) patients giving incorrect answer. The ACT score[21 (17, 23) vs 19 (15, 22) points; Z=-9.190, P<0.001] and asthma control rate (32.66% vs 22.20%; χ(2)=49.614, P<0.001) were significantly higher, and the rate of uncontrolled asthma (18.40% vs 25.00%; χ(2)=24.267, P<0.001) was significantly lower among the 2 321 (60.2%) patient correctly answering question 2 than among the 1 536 (39.8%) patients giving incorrect answer. Conclusions: Compared to previous surveys, there has been improved perception of disease among asthmatic patients in Chinese urban areas. Correct perception of disease is favorable for improving asthma control level.
Collapse
Affiliation(s)
- Y Nong
- Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Liang YM, Wang XN, Deng L, Wang L, Wang Y, Huang YJ, Liu TQ, Zuo HL, Sun QY, Qiao JH, Yu CL, Hu KX, Ai HS, Guo M. [Biological characteristics of Microvesicles Derived from Bone Marrow Mesenchymal Stem Cells and Their Capacities Supporting ex vivo Expansion of Hematopoietic Stem Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017; 25:1187-1193. [PMID: 28823290 DOI: 10.7534/j.issn.1009-2137.2017.04.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To explore the biological characteristics of microvesicles(MV) derived from bone marrow mesenchymal stem cells (BM-MSC) and their capability supporting ex vivo expansion of hematopoietic stem cells(HSC). METHODS The MV from cultured BM-MSC supernatant were isolated by multi-step differential velocity contrifugation; the morphological characteristics of MV were observed by electron microscopy with negative staining of samples; the protein level in MV was detected by using Micro-BCA method; the surface markers on MV were analyzed by flow cytometry. The peripheral blood HSC(PB-HSC) were isolated after culture and mobilization; the experiment was diveded into 2 group: in MV group, the 10 mg/L MV was given, while in control group, the same volume of PBS was given; the change of PB-HSC count was observed by cell counting; the change of surface markers on PB-HSC was detected dynamically by flow cytometry; the cell colony culture was used to determin the function change of PB-HSC after co-culture with MV. RESULTS MSC-MVs are 20-100 nm circular vesicles under electron microscope. About 10 µg protein could be extracted from every 1×106 MSC. The flow cytometry showed that CD63 and CD44 were positive with a rate of 96.0% and 50.2%, while the HLA-DR, CD34, CD29 and CD73 etc were negative. When being co-cultured with GPBMNC for 2 days, the cell number of MV groups was 1.49±0.15 times of the control group (P>0.05). When being co-cultured for 4 days, the cell number of MV groups was 2.20±0.24 times of the control group(P<0.05). The CD34+ cell number of MV groups was 1.76±0.30 times the control group after culture for 2 day and 1.95±0.20 times after culture for 4 day. CONCLUSION The MV has been successfully extracted from MSC culture supernatant by multi-step differential velocity centrifugation. MSC-MV can promote HSC expansion in vitro.
Collapse
Affiliation(s)
- Yu-Meng Liang
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Xiao-Na Wang
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Lei Deng
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Lu Wang
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Yi Wang
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Ya-Jing Huang
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Tie-Qiang Liu
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Hong-Li Zuo
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Qi-Yun Sun
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Jian-Hui Qiao
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Chang-Lin Yu
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Kai-Xun Hu
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Hui-Sheng Ai
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China
| | - Mei Guo
- Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071,China. E-mail:
| |
Collapse
|
30
|
Wu TS, Chen YW, Weng SC, Lin CN, Lai CH, Huang YJ, Jeng HT, Chang SL, Soo YL. Dramatic band gap reduction incurred by dopant coordination rearrangement in Co-doped nanocrystals of CeO 2. Sci Rep 2017; 7:4715. [PMID: 28680089 PMCID: PMC5498595 DOI: 10.1038/s41598-017-05046-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Accepted: 05/24/2017] [Indexed: 11/09/2022] Open
Abstract
A dramatic band gap narrowing of 1.61 eV has been observed in Co-doped nanocrystals of CeO2 (ceria), as a result of thermal annealing, without changing the ceria crystal structure and the Co concentration. As demonstrated by x-ray absorption fine structures, thermal annealing incurs an oxygen coordination rearrangement around Co atoms from an octahedral coordination to a square-planar coordination. First principle calculation using density functional theory reveals two stable oxygen coordination types surrounding Co, consistent with the experimental observation. The band gap values calculated for the two stable coordination types differ dramatically, reproducing the experimentally observed band gap narrowing. These prominent effects due to local structure rearrangement around dopant atoms can lead to unprecedented methods for band gap engineering in doped nanocrystal oxides.
Collapse
Affiliation(s)
- T S Wu
- Department of Physics, National Tsing Hua University, Hsinchu, Taiwan
| | - Y W Chen
- Department of Physics, National Tsing Hua University, Hsinchu, Taiwan
| | - S C Weng
- National Synchrotron Radiation Research Center, Hsinchu, Taiwan
| | - C N Lin
- Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan
| | - C H Lai
- Department of Materials Science and Engineering, National Tsing Hua University, Hsinchu, Taiwan
| | - Y J Huang
- Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan
| | - H T Jeng
- Department of Physics, National Tsing Hua University, Hsinchu, Taiwan.,Institute of Physics, Academia Sinica, Taipei, Taiwan
| | - S L Chang
- Department of Physics, National Tsing Hua University, Hsinchu, Taiwan.,National Synchrotron Radiation Research Center, Hsinchu, Taiwan
| | - Y L Soo
- Department of Physics, National Tsing Hua University, Hsinchu, Taiwan. .,National Synchrotron Radiation Research Center, Hsinchu, Taiwan.
| |
Collapse
|
31
|
Wang JH, Deng L, Wang L, Liang C, Wang Y, Liu TQ, Huang S, Huang YJ, Cai B, Dong Z, Zuo HL, Sun QY, Qiao JH, Yu CL, Hu KX, Ai HS, Guo M. [Effect of Infusion of Recipient Spleen Cells at Different Time after Murine Haploidentical Hematopoietic Stem Cell Transplantation on Graft Versus Host Disease]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017. [PMID: 28641651 DOI: 10.7534/j.issn.1009-2137.2017.03.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To explore the effect of infusing G-CSF mobilized recipient spleen cells at different time after haploidentical stem cell transplantation(HSCT) on graft-versus-host disease (GVHD) in mice and its possible mechanism. METHODS Forty mice after HSCT were randomly divided into 4 groups (n=10): GVHD positive control group (control group), 1st d recipient cell infusion group after transplantation (+1 d group), 4th d recipient cell infusion group after transplantation(+4 d group), 7th d recipient cell infusion group after transplantation(+7 d group). The mice in control group were injected the normal saline of same equivalent with experimental group which were given the same amount of G-CSF-mobilized recipient spleen cells. The general manifestation and pathological change of GVHD were observed. The expression changes of CD3+CD4+, CD3+CD8+ cell subsets and FasL in peripheral blood were detected by flow cytometry. RESULTS The incidence of GVHD was significantly decreased in +4 d group and the median survival time was longer than 60 days, which was significantly higher than that of control group (24 d), +1 d group (21 d), +7 d group (28 d). (P<0.01, P<0.01, P<0.01). The Fasl expression of peripheral blood T lymphocytes in +4 d group were significantly lower than that in the other 3 groups(P<0.05). CONCLUSION The +4 d infusion of G-CSF mobilized recipient spleen cells on 4th day after haploidentical HSC transplantation can inhibit the expression of FasL in donor T lymphocytes, and significantly reduce the incidence of GVHD.
Collapse
Affiliation(s)
- Jun-Hui Wang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Lei Deng
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Lu Wang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Chen Liang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Yi Wang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Tie-Qiang Liu
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Shan Huang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Ya-Jing Huang
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Bo Cai
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Zheng Dong
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Hong-Li Zuo
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Qi-Yun Sun
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Jian-Hui Qiao
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Chang-Lin Yu
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Kai-Xun Hu
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Hui-Sheng Ai
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China
| | - Mei Guo
- Department of Hematology, The Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China. E-mail: guom196801@ aliyun.com
| |
Collapse
|
32
|
Liang C, Wang JH, Deng L, Wang L, Wang Y, Huang YJ, Liu TQ, Cai B, Zuo HL, Sun QY, Qiao JH, Yu CL, Hu KX, Ai HS, Guo M. [Biological Characteristics of Microvesicles Secreted by Human Peripheral Blood Hematopoietic Stem Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017. [PMID: 28641610 DOI: 10.7534/j.issn.1009-2137.2017.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To investigate the effects of microvesicles(MV) isolated from human peripheral blood hematopoietic stem cells(PB-HSC) on immune regulation and hematopoiesis. METHODS PB-HSCs were separated by density-gradient centrifugation and cultrued. The supernatants of PB-HSC at 48 h were harvested for isolation and purification of MV by using ultracentrifugation. The electron microscopy was used to observe the morphology of MV. The protein level in MV was quantified through bicinchoninic acid(BCA) protein assay. Flow cytometry was used to detect the immunophenotype of MV. Human peripheral blood mononuclear cells(PB-MNC) were isolated from healthy donor and treated with isolated MV. After being co-cultured for 12 h, confocal microscopy was used to observe the action mode of MV on PB-MNC. After being co-cultured for 48 h, the levels of IL-2, IL-6, IL-8, IL-10, IFN-γ and TNF-α were detected by ELISA. Flow cytometry was used to detect the changes of T cell subsets and the activation of T cell subsets as well as intracellular cytokine staining after co-culture for 48 h. The methylcellulose was used to assess the hematopoiesis-supportive function of MV as well as co-cultured supernatants. RESULTS The eletron microscopy revealed that MV were elliptical membrane vesicles. The protein amount in MV ranges from 29 to 110 µg. Flow cytometry showed that MV expressed mix markers on the surface, especially highly expressed MV specific marker CD63(85.86%) and hematopoietic stem cell marker CD34(33.52%). After being co-cultured for 12 h, confocal microscopy showed that MV were merged with PB-MNC. After being co-cultured for 48 h, ELISA showed that the secretion of cytokines IL-6,IL-8, IL-10 as well as TNF-α was increased while the level of IL-2 and IFN-γ was not changed much. The results of flow cytometry showed that there was no significant change in T cell subsets and T cell activation. Staining of intracellular factor showed that IL-8 was increased significantly in CD11c+ cells. The colony-forming experiments revealed that MV and the co-cultured supernatants could facilitate the colony formation. CONCLUSION MV isolated from PB-HSC have immune-regulatery function and can prornote hematopoiesis.
Collapse
Affiliation(s)
- Chen Liang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Jun-Hui Wang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Lei Deng
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Lu Wang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Yi Wang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Ya-Jing Huang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Tie-Qiang Liu
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Bo Cai
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Hong-Li Zuo
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Qi-Yun Sun
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Jian-Hui Qiao
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Chang-Lin Yu
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Kai-Xun Hu
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Hui-Sheng Ai
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Mei Guo
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China. E-mail:
| |
Collapse
|
33
|
Fuh LJ, Huang YJ, Chen WC, Lin DJ. Preparation of micro-porous bioceramic containing silicon-substituted hydroxyapatite and beta-tricalcium phosphate. Materials Science and Engineering: C 2017; 75:798-806. [DOI: 10.1016/j.msec.2017.02.065] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2016] [Revised: 11/16/2016] [Accepted: 02/14/2017] [Indexed: 10/20/2022]
|
34
|
Wang XN, Liang YM, Deng L, Wang L, Wang Y, Huang YJ, Liu TQ, Zuo HL, Hu KX, Qiao JH, Sun QY, Guo M, Ai HS, Yu CL. [Establishment of Mouse Model of H-2 Haploidentical Hematopoietic Stem Cell Transplantation from Double Donors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017; 25:522-529. [PMID: 28446305 DOI: 10.7534/j.issn.1009-2137.2017.02.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To establish a new mouse model of H-2 haploidentical stem cell transplantation from double donors (DHSCT) and compare with conventional haploidentical hematopoietic stem cell transplantation (HSCT) so as to alleviate transplant-related complications. METHODS The recipients CB6F1 of conventional HSCT group were pretreated by 8 Gy total body irradiation(TBI), and received 3×107 donor (male C57) spleen mononuclear cells (spMNC) mobilized by G-CSF within 2 hours after TBI. Recipients CB6F1 of D-HSCT groups accepted 2 Gy TBI, and received total 12×107 spMNC mobilized by G-CSF from 2 donors within 2 hours after TBI, each donor donated 6×107 cells. According to the different strains and sex of donors, DHSCT were divided into 3 groups: in group A, the stem cells were from male C57 and female BALB/c; in group B, stem cells were from male C57 and male BALB/c, while the stem cells in group C were from male C57 and male C3H. Hematopoietic reconstruction, engraftment, GVHD and survival were observed among these 4 groups. RESULTS The nadir of white blood cell count after conventional HSCT were lower than 1×109/L and lasted for 3 to 5 days, while not less than 3×109/L after D-HSCT among either group A, B or C. The complete chimerism (CC) in conventional HSCT group was achieved quickly within only 1 week in peripheral blood. Mixed chimerism (MC) in peripheral blood was found within the first week after DHSCT among either group A, B or C, and transformed into stable CC within the second week eventually. Both GVHD morbidity and mortality of conventional HSCT were 100% at 34th day after transplantation.Among DHSCT groups,the overall GVHD morbidity and mortality at 34th day after transplant were 49.6% and 50%(P<0.01,P<0.05), respectively,and 60.4% and 81.2% at 50th day after transplant. Overall survival of 50 days was 50.9% that indicated a long survival in such mice DHSCT. The differences of hematopoietic reconstruction, donor cell engraftment, GVHD incidence, GVHD mortality and OS were not statistically significant among group A, B and C(P>0.05). CONCLUSION A new mouse model of H-2 haploidentical peripheral blood stem cell transplantation from double donors (DHSCT) has been successfully established by reducing conditioning intensity and increasing graft cell numbers from double haploidentical donors without GVHD prophylaxis. DHSCT successfully achieved stable complete chimerism, less GVHD morbidity and mortality and longer OS without hematopoietic suppression. This study provides experimental evidence for clinical application of HLA haploidentical peripheral blood stem cell transplantation from double donors.
Collapse
Affiliation(s)
- Xiao-Na Wang
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Yu-Meng Liang
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Lei Deng
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Lu Wang
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Yi Wang
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Ya-Jing Huang
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Tie-Qiang Liu
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Hong-Li Zuo
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Kai-Xun Hu
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Jian-Hui Qiao
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Qi-Yun Sun
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Mei Guo
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Hui-Sheng Ai
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China
| | - Chang-Lin Yu
- Department of Hematology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing 100071,China.E-mail: fische1224@sohu .com
| |
Collapse
|
35
|
Huang YJ, Zheng YQ, Wang JJ, Zhou LX. A new bismuth-based coordination polymer as an efficient visible light responding photocatalyst under white LED irradiation. J SOLID STATE CHEM 2017. [DOI: 10.1016/j.jssc.2016.10.028] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
36
|
Liu TQ, Huang S, Yao B, Liu ZQ, Yu CL, Qiao JH, Sun QY, Hu KX, Huang YJ, Zhang R, Li YF, Bai J, Sun YJ, Li BX, Wang DM, Wang Y, Guo M. [Features of Immunophenotypes and Characteristics of Molecular Biology and Cellular Genetics of AML Patients with CD4 and CD7 Expression]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24:1627-1632. [PMID: 28024467 DOI: 10.7534/j.issn.1009-2137.2016.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To explore the features of immunophenotypes and the characteristics of molecular biology and cellular genetics of AML patients with CD7 and CD4 expression. METHODS The immunophenotypical markers of AML cells were detected by multiple parameter flow cytometry; the expression of WT1, MDK, ETO, PML-RaRa and BCR-ABL were detected by RT-PCR; and cellular features were analyzed by R-band in 304 patients. The patients were divided into three groups according to their immunophenotypes: AML with CD7 expression (CD7 group), AML with CD4 expression(CD4 group) and AML without CD7 and CD4 expression (common AML group). RESULTS The expression rate and level of HLA-DR in CD7 group were higher than those in the common AML group, and the expression rate of CD33 and CD34 was higher than that in the other two groups. The expression rate and level of CD15, CD64 in the CD4 group were higher than those in the other 2 groups, and the expression rate and level of CD33 were higher than those in the common AML group. WT1 expression in the CD7 group was lower than that in the common AML group. PML-RaRa was not detected in the CD7 group. AML with co-expression of CD4 or CD7 showed more normal karyotype. (15;17) was not found in AML with CD7 expression. CONCLUSION AML cells with CD7 expression originate from precursor cells and are blocked in the early phase of hematological development; AML cells with CD4 expression originate from more mature stage of hematological devevelopment and with CD33, CD64 and CD15 high expression; AML cells with CD7 and CD4 expression are characterized by no-specific change of cellular genetics. According to the expression level and intesity of CD4 and CD7, and together with other specific lineage markers, the MRD in AML patients can be quantitatively detected.
Collapse
Affiliation(s)
- Tie-Qiang Liu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Shan Huang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Bo Yao
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Zhi-Qing Liu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Chang-Lin Yu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Jian-Hui Qiao
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Qi-Yun Sun
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Kai-Xun Hu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Ya-Jing Huang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Rui Zhang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Yu-Fang Li
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Juan Bai
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Yu-Jing Sun
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Bing-Xia Li
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Dong-Mei Wang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Yi Wang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Mei Guo
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| |
Collapse
|
37
|
Yu CL, Qiao ZH, Wang JM, Liang YM, Wu DP, Chen BA, Shi BF, Sun WJ, Qiao JX, Guo M, Qiao JH, Sun QY, Hu KX, Huang YJ, Zuo HL, Huang XJ, Ai HS. The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group. Ann Hematol 2016; 96:279-288. [PMID: 27864604 DOI: 10.1007/s00277-016-2864-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2016] [Accepted: 10/20/2016] [Indexed: 11/26/2022]
Abstract
This study compared 6-year follow-up data from patients undergoing reduced-intensity conditioning (RIC) transplantation with an HLA-matched related donor (MRD), an HLA-matched unrelated donor (MUD), or an HLA-haploidentical donor (HID) for leukemia. Four hundred and twenty-seven patients from the China RIC Cooperative Group were enrolled, including 301 in the MRD, 79 in the HID, and 47 in the MUD groups. The conditioning regimen involved fludarabine combined with anti-lymphocyte globulin and cyclophosphamide. Graft-versus-host disease (GVHD) prophylaxis was administered using cyclosporin A (CsA) and mycophenolate mofetil (MMF). Four hundred and nineteen patients achieved stable donor chimerism. The incidence of stage II-IV acute GVHD in the HID group was 44.3 %, significantly higher than that in the MRD (23.6 %) and MUD (19.1 %) groups. The 1-year transplantation-related mortality (TRM) rates were 44.3, 17.6, and 21.3, respectively. Event-free survival (EFS) at 6 years in the HID group was 36.7 %, significantly lower than that of the MRD and MUD groups (59.1 and 66.0 %, P < 0.001 and P = 0.001, respectively). For advanced leukemia, the relapse rate of the HID group was 18.5 %, lower than that of the MRD group (37.5 %, P = 0.05), but the EFS at 6 years was 31.7 and 30.4 % (P > 0.05), respectively. RIC transplantation with MRD and MUD had similar outcome in leukemia which is better than that with HID. RIC transplantation with HID had lower relapsed with higher TRM and GVHD rate, particularly in advanced leukemias. RIC transplantation with MRD and MUD had similar outcomes in leukemia and they were better than those with HID. RIC transplantation with HID had a lower relapse rate but higher TRM and GVHD rates, particularly in cases of advanced leukemia.
Collapse
Affiliation(s)
- Chang-Lin Yu
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Zhen-Hua Qiao
- Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Jian-Min Wang
- Chang Hai Hospital of Shanghai Second Military Medical University, Shanghai, China
| | - Ying-Min Liang
- Tang-Du Hospital of Fourth Military Medical University, Xi'an, China
| | - De-Pei Wu
- Affiliated Hospital of Suzhou University, Suzhou, China
| | - Bao-An Chen
- Affiliated Zhongda Hospital of Southeast University, Nanjing, China
| | | | - Wan-Jun Sun
- Second Artillery General Hospital, Beijing, China
| | | | - Mei Guo
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Jian-Hui Qiao
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Qi-Yun Sun
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Kai-Xun Hu
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Ya-Jing Huang
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Hong-Li Zuo
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China
| | - Xiao-Jun Huang
- Department of Hematology and Transplantation, People's Hospital Under Beijing University, Beijing, 100044, China.
| | - Hui-Sheng Ai
- Department of Hematology and Transplantation, Affiliated Hospital of the Academy of Military Medical Sciences, 8 Dongdajie, Beijing, 100071, China.
| |
Collapse
|
38
|
Yuan Y, Li LH, Huang YJ, Lei LF. Tiapride is more effective and causes fewer adverse effects than risperidone in the treatment of senile dementia. Eur Rev Med Pharmacol Sci 2016; 20:3119-3122. [PMID: 27460743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE We wanted to compare the effects of tiapride and risperidone in treating behavioral and psychological symptoms of senile dementia. PATIENTS AND METHODS 108 patients with senile dementia received respective treatments (54 patients per treatment, either with 100 mg/day risperidone or 2.0 mg tiapride/day) for 2 months. Outcomes included the positive and negative syndrome scale (PANSS) scores, the curative rate of senile dementia, and prevalence of adverse effects (somnolence, headache, loss of weight, extrapyramidal system response, irritation and insomnia). RESULTS PANSS scores before treatment were comparable between treatment groups. On days 7, 15, 30, and 60 of the treatment, the differences between two treatment groups became evident. Thus, curative rates in patients treated with risperidone were 74.1% and in those treated with tiapride 88.9% (p < 0.05). Prevalence of adverse reactions was significantly lower in the latter group (9.3% vs. 25.9% in patients treated with risperidone; p < 0.05). CONCLUSIONS Tiapride is more effective in improving clinical symptoms of senile dementia and causes fewer adverse effects.
Collapse
Affiliation(s)
- Y Yuan
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | | | | | | |
Collapse
|
39
|
Huang YJ, Zheng YQ, Zhu HL, Wang JJ. Hydrothermal synthesis of Bismuth(III) coordination polymer and its transformation to nano α-Bi2O3 for photocatalytic degradation. J SOLID STATE CHEM 2016. [DOI: 10.1016/j.jssc.2016.05.006] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Pang SY, Liu HY, Huang YJ, Liu YF, Dai YM, Zeng P, Zeng HS. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis. Genet Mol Res 2016; 15:gmr8641. [PMID: 27323035 DOI: 10.4238/gmr.15028641] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The prevalence rates of anti-citrullinated protein/peptide antibodies (ACPAs) were investigated in a cohort of juvenile idiopathic arthritis (JIA) patients, and their diagnostic performances were compared. ACPAs, including anti-cyclic citrullinated peptide IgG (anti-CCP), anti-CCP IgG/IgA (anti-CCP3.1), citrullinated recombinant rat filaggrin antibodies (CPA), anti-mutated citrullinated vimentin (anti-MCV), and antibodies to citrullinated human IgG-derived peptides (RA/CP), were measured in the sera from 81 JIA patients. Serum samples from 55 children with other joint diseases or viral infections and 49 healthy donors were tested as controls. Of the 81 JIA patients, 7 (8.6%), 8 (9.9%), 17 (21.0%), 23 (28.4%), and 18 (22.2%) were found to be positive for anti-CCP, anti-CCP3.1, CPA, anti-MCV, and RA/CP, respectively, with specificities of 98.1, 95.1, 93.3, 84.6, and 86.5%. Analysis by subtype revealed that 7/7 (100%) of RF-positive polyarticular JIA patients tested positive at high serum levels for anti-MCV or RA/CP, and 5/7 (71.4%) were positive for anti-CCP, anti- CCP3.1, or CPA (P < 0.001, compared with controls). Eighteen of 81 JIA patients demonstrated joint erosions on radiographs and erosive arthritis occurred more often in ACPAs positive patients (P < 0.01). Our findings indicate that although ACPAs are not satisfactory screening biomarkers for JIA due to low sensitivity, ACPA measurement can aid in diagnosing RF-positive polyarticular JIA and identifying JIA patients with severe bone involvement. The diagnostic performance of each ACPA in JIA is different, and the careful selection of assays is necessary.
Collapse
Affiliation(s)
- S Y Pang
- Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - H Y Liu
- Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - Y J Huang
- Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - Y F Liu
- Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - Y M Dai
- Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - P Zeng
- Department of Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| | - H S Zeng
- Department of Immunology and Rheumatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China
| |
Collapse
|
41
|
He YM, Yao SW, Huang YJ, Liang BS, Liu HY. Investigating the recheck rules for urine analysis in children. Genet Mol Res 2016; 15:gmr7349. [PMID: 27173232 DOI: 10.4238/gmr.15027349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The aim of this study was to establish recheck rules of urinalysis in children by investigating the concordance rate of the results obtained using the LabUMat urine dry chemistry analyzer (referred to as dry chemistry) and the UriSed tangible composition analyzer with that of the microscopic examination. First, 1040 urine samples from children (mean age 6.5 years) were analyzed using LabUMat and UriSed analyzers, and subsequently subjected to microscopic examination. The missed detection rate was evaluated and recheck rules were established to avoid missed diagnoses of abnormal renal function. Finally, clinical validations of the recheck rules were performed on 200 additional specimens. Among the samples used to investigate the recheck rules, the samples with positive microscopic examination results accounted for 58.65% of the total, while the samples with negative results accounted for 41.35%. Of the positive samples, a major portion (>50%) were RBC positive. The samples that were WBC positive and CAST positive accounted for 23.08 and 7.69%, respectively. The concordance rate was 87.5% and the missed detection rate was 2.9%. For the validation of the recheck rules in 200 urine samples, the concordance rate was 87.5% and the missed detection rate was 2.4%. When the detection of occult blood, WBC, and protein by dry chemistry, and the detection of RBC, WBC, and CAST by the UriSed analyzer are inconsistent, or the differences between them greater than 2 levels, recheck by microscopic examination is suggested.
Collapse
Affiliation(s)
- Y M He
- Department of Traumatology and Microsurgery, The Third Clinical College, Southern Medical University
| | - S W Yao
- Department of Traumatology and Microsurgery, The Third Clinical College, Southern Medical University
| | - Y J Huang
- Department of Traumatology and Microsurgery, The Third Clinical College, Southern Medical University
| | - B S Liang
- Department of Traumatology and Microsurgery, The Third Clinical College, Southern Medical University
| | - H Y Liu
- Department of Traumatology and Microsurgery, The Third Clinical College, Southern Medical University
| |
Collapse
|
42
|
Sung CL, Lee CY, Cho HH, Huang YJ, Chen YF, Pan ZB, Yu HH, Zhang HJ, Wang JY. Theoretical and experimental studies for high-repetition-rate disordered crystal lasers with harmonic self-mode locking. Opt Express 2016; 24:3832-3838. [PMID: 26907036 DOI: 10.1364/oe.24.003832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
A harmonically self-mode-locked Nd:Sr3Y2/(BO3)4 disordered crystal laser with subpicosecond pulse duration is demonstrated. We exploit the damped harmonic oscillator model to numerically verify that the mode spacing of the laser cavity can be modified to be the harmonics of the free spectral range of the Fabry-Perot cavity when the optical length of the laser cavity is close to a commensurate ratio of the optical length of the Fabry-Perot cavity. In experiment, the Fabry-Perot cavity can be formed by the pump facet of the disordered crystal and the front mirror. A 110 GHz single-pulse harmonically mode-locked pulse train with pulse duration of 857 fs is experimentally achieved under optical lengths of 27.19 and 4.08 mm for the laser cavity and Fabry-Perot cavity respectively, corresponding to a fractional number of 20/3. A maximum output power of 162 mW is obtained at an incident pump power of 3.1 W.
Collapse
|
43
|
Hu KX, Sun QY, Guo M, Qiao JX, Yu CL, Qiao JH, Dong Z, Sun WJ, Zuo HL, Huang YJ, Cai B, Ai HS. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia. Stem Cells Transl Med 2016; 5:524-9. [PMID: 26838271 DOI: 10.5966/sctm.2015-0196] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2015] [Accepted: 11/02/2015] [Indexed: 12/11/2022] Open
Abstract
UNLABELLED The treatment outcomes of myelodysplastic syndrome (MDS) and transformed acute myelogenous leukemia (tAML) remain very unsatisfactory. We designed a combination of human leukocyte antigen (HLA)-mismatched hematopoietic stem cell microtransplantation (MST) with chemotherapy for patients with MDS and tAML and evaluated its effects and toxicity. Patients were between 13 and 79 years old. Patients with MDS (n=21) were given HLA-mismatched MST combined with decitabine and cytarabine; patients with tAML (n=22) were given HLA-mismatched MST combined with decitabine and cytarabine, and also mitoxantrone. Patients in complete remission (CR) also received MST plus decitabine and medium-dose cytarabine chemotherapy without graft-versus-host disease (GVHD) prophylaxis. The overall response rate of the patients with MDS was significantly higher than that of those with tAML (81% vs. 50%; p=.03). The CR rates were 52.4% and 36.4% in the two groups, respectively. There was no difference in the cytogenetic CR rate between the MDS and tAML groups (85.7% vs. 70%, respectively; p=.7). The 24-month overall survival of the patients with MDS was significantly higher than that of the patients with tAML (84.7% and 34.1%, respectively; p=.003). The median recovery times of neutrophils and platelets were, respectively, 14 and 17 days in the patients with MDS, and 16 and 19 days in those with tAML. The treatment-related mortality rates were 4.8% and 18.2%, respectively, in the MDS and tAML groups (p=.34). No GVHD was observed in any patient. Microtransplantation combined with decitabine and chemotherapy may provide a novel, effective, and safe treatment for high-risk MDS and tAML. SIGNIFICANCE Microtransplantation (MST) refers to regular chemotherapy combined with granulocyte colony-stimulating factor-mobilized peripheral blood stem cell infusion of human leukocyte antigen-mismatched donor cells without using immunosuppressive agents. It aims to support hematopoietic recovery and perform graft-versus-leukemia (GVL) effects but differs from traditional allogeneic stem cell transplantation because the rate of donor cell chimerism is low and there is and no graft-versus-host disease (GVHD) risk. Thus, a trial was designed to evaluate the safety and efficacy of MST in patients with myelodysplastic syndrome and those with transformed acute myelogenous leukemia. Higher complete remission and cytogenetic complete response rates were observed, and the treatment improved disease progress-free survival, sped hematopoietic recovery, and avoided GVHD.
Collapse
Affiliation(s)
- Kai-Xun Hu
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Qi-Yun Sun
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Mei Guo
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Jun-Xiao Qiao
- Department of Hematology, Second Artillery General Hospital, Beijing, People's Republic of China
| | - Chang-Lin Yu
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Jian-Hui Qiao
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Zheng Dong
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Wan-Jun Sun
- Department of Hematology, Second Artillery General Hospital, Beijing, People's Republic of China
| | - Hong-Li Zuo
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Ya-Jing Huang
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Bo Cai
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| | - Hui-Sheng Ai
- Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People's Republic of China
| |
Collapse
|
44
|
Huang YJ, Jestin C, Welham SJ, King GJ, Manzanares-Dauleux MJ, Fitt BDL, Delourme R. Identification of environmentally stable QTL for resistance against Leptosphaeria maculans in oilseed rape (Brassica napus). Theor Appl Genet 2016; 129:169-80. [PMID: 26518572 PMCID: PMC4703627 DOI: 10.1007/s00122-015-2620-z] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2015] [Accepted: 10/09/2015] [Indexed: 05/18/2023]
Abstract
Six stable QTL for resistance against L. maculans (phoma stem canker) have been identified by QTL × environment interaction analysis using data from five winter oilseed rape field experiments. Phoma stem canker, caused by Leptosphaeria maculans, is a disease of worldwide importance on oilseed rape (Brassica napus). Quantitative trait loci (QTL)-mediated resistance against L. maculans in B. napus is considered to be race non-specific and potentially durable. Identification and evaluation of QTL for resistance to L. maculans is important for breeding oilseed rape cultivars with durable resistance. An oilseed rape mapping population was used to detect QTL for resistance against L. maculans in five winter oilseed rape field experiments under different environments. A total of 17 QTL involved in 'field' quantitative resistance against L. maculans were detected and collectively explained 51% of the phenotypic variation. The number of QTL detected in each experiment ranged from two to nine and individual QTL explained 2-25% of the phenotypic variation. QTL × environment interaction analysis suggested that six of these QTL were less sensitive to environmental factors, so they were considered to be stable QTL. Markers linked to these stable QTL will be valuable for selection to breed for effective resistance against L. maculans in different environments, which will contribute to sustainable management of the disease.
Collapse
Affiliation(s)
- Y J Huang
- Centre for Agriculture, Food and Environmental Management, University of Hertfordshire, Hatfield, Hertfordshire, AL10 9AB, UK.
- Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, UK.
| | - C Jestin
- Terres Inovia, 78850, Thiverval-Grignon, France
- INRA, UMR1349 IGEPP, BP 35327, 35653, Le Rheu Cedex, France
| | - S J Welham
- Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, UK
- VSN International Ltd, Waterhouse Street, Hemel Hempstead, Hertfordshire, HP1 1ES, UK
| | - G J King
- Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, UK
- Southern Cross University, Lismore, NSW, 2480, Australia
| | - M J Manzanares-Dauleux
- INRA, UMR1349 IGEPP, BP 35327, 35653, Le Rheu Cedex, France
- Agrocampus Ouest, UMR1349 IGEPP, BP 35327, 35653, Le Rheu Cedex, France
| | - B D L Fitt
- Centre for Agriculture, Food and Environmental Management, University of Hertfordshire, Hatfield, Hertfordshire, AL10 9AB, UK
- Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, UK
| | - R Delourme
- INRA, UMR1349 IGEPP, BP 35327, 35653, Le Rheu Cedex, France
| |
Collapse
|
45
|
Liu J, Sun WJ, Zhao HX, Li J, Huang YJ, Xi XQ, Hu HL. [Clinical Analysis of 4 AML Patients Aged Over 80 Years Treated with Chemotherapy Combined with Haploidentical Hematopoietic Stem Cell Infusion]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2015; 23:1679-83. [PMID: 26708893 DOI: 10.7534/j.issn.1009-2137.2015.06.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To investigate the efficacy and safety of MA (mitoxantrone and cytarabine) regimen chemotherapy combined with granulocyte-colony stimulating factor (G-CSF)-mobilized family related HLA-haploidentical donor peripheral blood hematopoietic stem cell (G-PBHSC) infusion for the treatment of acute myeloid leukemia (AML) patients aged over 80 years. METHODS Four elderly patients with AML were treated in Chinese Second Artillery General Hospital from August 2008 to September 2013. The proportion of male to female was 1 : 3 and the median age 83 (80-85) years. All patients received programmed infusions of G-PBHSC after MA regimen chemotherapy without graft-versus-host disease (GVHD) prophylaxis. After complete remission (CR), patients only received G-PBHSC infusion without chemotherapy. RESULTS Three cases achieved CR and their disease free survival (DFS) time was 18, 8, 6 months, respectively. 1 case did not reach remission after 2 cycles chemotherapy. The median overall survival (OS) time was 10 (3-20) months. No GVHD was observed in any of the patients during treatment. Concludsion: The combination of chemotherapy and programmed haploidentical G-PBHSC infusion is an alternative approach for AML patients aged over 80 years.
Collapse
Affiliation(s)
- Juan Liu
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| | - Wan-Jun Sun
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China. E-mail:
| | - Hong-Xia Zhao
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| | - Jie Li
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| | - Ya-Jing Huang
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| | - Xiao-Qin Xi
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| | - Hai-Lan Hu
- Department of Hematology, The Second Artillery General Hospital of Chinese PLA, Beijing 100088, China
| |
Collapse
|
46
|
Zhu K, Fu Q, Zhang N, Huang YJ, Zhang Q. Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction. Eur Rev Med Pharmacol Sci 2015; 19:4636-4641. [PMID: 26698262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE This study aimed to compare preoperative treatment using clopidogrel and ticagrelor for patients with acute myocardial infarction (AMI) undergoing emergent percutaneous coronary intervention (PCI), and to investigate the efficacy and safety of these medications in the management of AMI. PATIENTS AND METHODS Between February 2013 and December 2014, 74 patients with AMI admitted for emergent PCI therapy were included in the study and randomly divided into two groups: study group and control group. Patients in the study group received different pre-PCI treatment with a loading dose of 180 mg ticagrelor, and those in the control group received treatments with a loading dose of 600 mg clopidogrel. After PCI procedure, all patients were orally administered 75 mg clopidogrel once a day for maintenance therapy, and patients were monitored for one week at the hospital and further followed up for one month Platelet aggregation rates (PAR) of each patient was measured before medication, at 30 min, 2h, 24h and one week after medication, respectively. PAR, thrombolysis in myocardial infarction (TIMI) flow, clinical outcomes and adverse reactions were compared between groups. RESULTS No significant differences were observed in PAR before treatment between groups (p>0.05), whereas PARs were significantly different after treatment between groups (p<0.05), with the efficacy of medications peaking at 2h after the treatment. In addition, PARs were significantly different between different time points after treatment (p<0.05). Evaluation of TIMI flow grade showed that in study group, 6 patients (16.22%) were grade 2 and 31 (83.78%) were grade 3 for the study group; for the control group, 11 patients (27.73%) were grade 2 and 26 (72.27%) were grade 3. No significant differences were observed in TIMI flow grades between different groups (p>0.05). No recurrence of the disease was observed, but one case (2.70%) of mucosal bleeding in the nasal cavity and four cases (10.81%) of vomiting were found in the study group. However, in the control group, four patients (10.81%) presented with recurrent disease, six patients (16.22%) experienced mucosal bleeding in the nasal cavity and 11 patients (29.73%) vomited. Significant differences were observed in the incidence of adverse events between different groups (p<0.05). CONCLUSIONS Compared with 600 mg clopidogrel, a loading dose of 180 mg ticagrelor could effectively inhibit platelet reactivity at the early stage of AMI, resulting in more favorable clinical outcomes and lower occurrence of adverse events and, thereby, can be used in clinical practice.
Collapse
Affiliation(s)
- K Zhu
- Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
| | | | | | | | | |
Collapse
|
47
|
Wu Y, Chen X, Chang X, Huang YJ, Bao S, He Q, Li Y, Zheng J, Duan T, Wang K. Potential involvement of placental AhR in unexplained recurrent spontaneous abortion. Reprod Toxicol 2015; 59:45-52. [PMID: 26593447 DOI: 10.1016/j.reprotox.2015.11.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2015] [Revised: 11/05/2015] [Accepted: 11/16/2015] [Indexed: 11/29/2022]
Abstract
Recurrent spontaneous abortion (RSA) is a common complication of pregnancy. Recent studies have demonstrated that the aryl hydrocarbon receptor (AhR) might play important roles in establishing and maintaining early pregnancy. In this study, we found that placental AhR protein levels were significantly lower and placental CYP1A1 mRNA levels were higher in unexplained RSA (URSA) patients than in control subjects. The results of immunohistochemical analyzes showed that placental AhR was expressed in syncytiotrophoblast cells and that the level of AhR was markedly lower in these cells in URSA subjects than in control subjects. β-Naphthoflavone (β-NF, an AhR ligand) at 5μM significantly inhibited proliferation and migration in HTR-8/SVneo cells and was associated with the activation of AhR. Moreover, overexpressing AhR in JAR cells significantly increased CYP1A1 mRNA levels and inhibited cell migration. These results indicate that AhR is highly activated in URSA placentas and that the activation of AhR in the placenta might impair trophoblast cell proliferation and migration, possibly leading to the occurrence of URSA.
Collapse
Affiliation(s)
- Y Wu
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - X Chen
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - X Chang
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - Y J Huang
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - S Bao
- Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - Q He
- Department of Pathology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China
| | - Y Li
- Department of Ob./Gyn., University of Wisconsin-Madison, Madison, WI 53715 USA
| | - J Zheng
- Department of Ob./Gyn., University of Wisconsin-Madison, Madison, WI 53715 USA
| | - T Duan
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China; Department of Obstetrics, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China.
| | - K Wang
- Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040 PR China.
| |
Collapse
|
48
|
Ruiz-Jasbon F, Ticehurst K, Norrby J, Ahonen J, Ivarsson ML, Klimovska T, Mukans M, Niciporuka R, Ivanovs I, Pupelis G, El-Bakary T, Bouchiba N, El-Faki A, El-Akkad M, Dabic D, Maric B, Perunicic V, Chung M, Amerio G, Pozzo G, Sorisio V, Peng L, Huang K, Huang YJ, Yang YC, Hu SX, Zhao G. Topic: Inguinal Hernia - Crossfire between the meshes. Hernia 2015; 19 Suppl 1:S251-3. [PMID: 26518817 DOI: 10.1007/bf03355365] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- F Ruiz-Jasbon
- Department of Surgery, Holland's Hospital, Kungsbacka, Sweden.,Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden
| | - K Ticehurst
- Department of Surgery, Holland's Hospital, Kungsbacka, Sweden
| | - J Norrby
- Department of Surgery, Holland's Hospital, Kungsbacka, Sweden.,Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden
| | - J Ahonen
- Department of Surgery, Holland's Hospital, Kungsbacka, Sweden
| | - M-L Ivarsson
- Department of Surgery, Holland's Hospital, Kungsbacka, Sweden.,Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden
| | - T Klimovska
- Department of General and Emergency Surgery, Riga East Clinical University Hospital Gailezers, Riga, Latvia
| | - M Mukans
- Department of General and Emergency Surgery, Riga East Clinical University Hospital Gailezers, Riga, Latvia
| | - R Niciporuka
- Surgery department, Pauls Stradins Clinical University Hospital, Riga, Latvia
| | - I Ivanovs
- Department of General and Emergency Surgery, Riga East Clinical University Hospital Gailezers, Riga, Latvia
| | - G Pupelis
- Department of General and Emergency Surgery, Riga East Clinical University Hospital Gailezers, Riga, Latvia
| | - T El-Bakary
- Al-wakra Hospital, Hamad Medical Corporation, Doha, Qatar
| | | | | | | | - D Dabic
- Department of surgery, General Hospital Cacak, Cacak, Serbia
| | | | | | - M Chung
- Gil Medical Center, Gachon University, Incheon, South Korea
| | - G Amerio
- Department of Surgery, Cardinal Massaia Hospital, Asti, Italy
| | | | | | - L Peng
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| | - K Huang
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| | - Y J Huang
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| | - Y C Yang
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| | - S X Hu
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| | - G Zhao
- Department of General Surgery for Vascular Disease, Thyroid Gland and Hernia, Guangdong General Hospital, Guangdong Aca, Guangzhou, China
| |
Collapse
|
49
|
Hong L, Huang YJ, Yong WA. A Kinetic Model for Cell Damage Caused by Oligomer Formation. Biophys J 2015; 109:1338-46. [PMID: 26445435 DOI: 10.1016/j.bpj.2015.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Revised: 07/27/2015] [Accepted: 08/11/2015] [Indexed: 11/25/2022] Open
Abstract
It is well known that the formation of amyloid fiber may cause invertible damage to cells, although the underlying mechanism has not been fully understood. In this article, a microscopic model considering the detailed processes of amyloid formation and cell damage is constructed based on four simple assumptions, one of which is that cell damage is raised by oligomers rather than mature fibrils. By taking the maximum entropy principle, this microscopic model in the form of infinite mass-action equations together with two reaction-convection partial differential equations (PDEs) has been greatly coarse-grained into a macroscopic system consisting of only five ordinary differential equations (ODEs). With this simple model, the effects of primary nucleation, elongation, fragmentation, and protein and seeds concentration on amyloid formation and cell damage have been extensively explored and compared with experiments. We hope that our results will provide new insights into the quantitative linkage between amyloid formation and cell damage.
Collapse
Affiliation(s)
- Liu Hong
- Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Peking, P.R. China.
| | - Ya-Jing Huang
- Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Peking, P.R. China
| | - Wen-An Yong
- Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Peking, P.R. China
| |
Collapse
|
50
|
Wang SF, Huang YJ, Yu CL, Sun QY, Qiao JH, Hu KX, Zuo HL, Dong Z, Liu ZQ, Wang Y, Huang XM, Ai HS, Guo M. [Efficacy of Nonmyeloablative Allogeneic Hematopoietic Stem Cells for 14 Case of Severe Acquired Aplastic Anemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2015; 23:1097-102. [PMID: 26314453 DOI: 10.7534/j.issn.1009-2137.2015.04.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To investigate the therapeutic efficacy of nonmyeloablative allogeneic hematopoietic stem cells transplantation for severe acquired aplastic anemia (SAA). METHODS Fourteen patients with severe acquired aplastic anemia received nonmyeloablative allogeneic hematopoietic stem cells transplantation from HLA matched sibling donors, among them 8 cases were dagnosed as SAA-I, 6 cases were diagnosed as SAA-II. The conditioning regimen consisted of fludarabine (FIUD), cyclophosphamide (CTX) and anti-thymocyte globulin (ATG/ALG). The prophylaxis for graft-versus-host disease (GVHD) was performed with cyclosporine (CsA) combined with mycophenolate mofetil (MMF) or tacrolimus (FK506). RESULTS All the patients gained a quick successfully engraftment of donor hametopoietic cells. The mean recovery time for neutrophil and platelet was 9 d and 13 d respectively. All the patients have acquired a full donor chimerism before 14 d. There were only 2 cases of GVHD: one out of them was acute skin GVHD (grade I) at day 70 after transplantation and the other was chronic liver GVHD (grade I) in 1 years after transplantation, the GVHD more than degree II did not coccur in all patients, 9 patients with bacterial and fungal mixed infection and (or) virus infection were observed, and improved after anti-infection therapy. The median follow-up time were 54.5 months (ranged between 5-144 months), and 12 patients remain disease-free survival currently, only 2 patients died of fungal infectin. CONCLUSION Transplantation of nonmyeloablative allogeneic hematopoietic stem cell is safe and effective for the treatment of severe acquired aplastic, but the prevention, treatment and monitoring of infection need to be enhance.
Collapse
Affiliation(s)
- Shao-Fei Wang
- School of Postgraduate, Anhui Medical University, Hefei 230032, Anhui Province, China.,Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Ya-Jing Huang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Chang-Lin Yu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Qi-Yun Sun
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Jian-Hui Qiao
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Kai-Xun Hu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Hong-Li Zuo
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Zheng Dong
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Zhi-Qing Liu
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Yi Wang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Xiao-Mei Huang
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Hui-Sheng Ai
- Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
| | - Mei Guo
- School of Postgraduate, Anhui Medical University, Hefei 230032, Anhui Province, China.,Department of Hematology, The Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China. E-mail:
| |
Collapse
|